Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 419.
A
|
Abdelnour, C;
van Steenoven, I;
Londos, E;
Blanc, F;
Auestad, B;
Kramberger, MG;
Zetterberg, H;
... Aarsland, D; + view all
(2019)
Correction: Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
[Corrigendum].
Movement Disorders
, 34
(4)
p. 593.
10.1002/mds.27672.
|
Aldous, Sarah Grace;
(2019)
S-Nitrosylation of the NuRD Complex in Cortical Neurons.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Allison, SL;
Koscik, RL;
Cary, RP;
Jonaitis, EM;
Rowley, HA;
Chin, NA;
Zetterberg, H;
... Johnson, SC; + view all
(2019)
Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
NeuroImage: Clinical
, 23
, Article 101895. 10.1016/j.nicl.2019.101895.
|
 |
|
Altomare, D;
Ferrari, C;
Caroli, A;
Galluzzi, S;
Prestia, A;
van der Flier, WM;
Ossenkoppele, R;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2019)
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
Journal of Neurology
, 266
pp. 2535-2545.
10.1007/s00415-019-09441-7.
|
|
Alvén, J;
Heurling, K;
Smith, R;
Strandberg, O;
Schöll, M;
Hansson, O;
Kahl, F;
(2019)
A Deep Learning Approach to MR-less Spatial Normalization for Tau PET Images.
In: Shen, D and Liu, T and Peters, TM and Staib, LH and Essert, C and Zhou, S and Yap, PT and Khan, A, (eds.)
Medical Image Computing and Computer Assisted Intervention – MICCAI 2019: 22nd International Conference, Shenzhen, China, October 13–17, 2019, Proceedings, Part II.
(pp. pp. 355-363).
Springer: Cham, Switzerland.
|
|
Anderson, D;
Ferreira-Correia, A;
Brogueira Rodrigues, F;
Aziz, A;
Carr, J;
Wild, E;
Margolis, R;
(2019)
Comparison of the Huntington’s disease-like 2 and Huntington’s disease clinical phenotypes.
Movement Disorders Clinical Practice
(In press).
|
|
Andersson, A;
Remnestål, J;
Nellgård, B;
Vunk, H;
Kotol, D;
Edfors, F;
Uhlén, M;
... Fredolini, C; + view all
(2019)
Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease.
Clinica Chimica Acta
, 494
pp. 79-93.
10.1016/j.cca.2019.03.243.
|
|
|
Arber, C;
Villegas-Llerena, C;
Toombs, J;
Pocock, JM;
Ryan, NS;
Fox, NC;
Zetterberg, H;
... Wray, S; + view all
(2019)
Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout.
Brain Communications
10.1093/braincomms/fcz024.
(In press).
|
|
|
Arboleda-Velasquez, JF;
Lopera, F;
O'Hare, M;
Delgado-Tirado, S;
Marino, C;
Chmielewska, N;
Saez-Torres, KL;
... Quiroz, YT; + view all
(2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nature Medicine
, 25
(11)
pp. 1680-1683.
10.1038/s41591-019-0611-3.
|
|
Ashton, NJ;
Ide, M;
Zetterberg, H;
Blennow, K;
(2019)
Salivary Biomarkers for Alzheimer's Disease and Related Disorders.
Neurology and Therapy
, 8
(S2)
pp. 83-94.
10.1007/s40120-019-00168-1.
|
|
|
Ashton, NJ;
Leuzy, A;
Lim, YM;
Troakes, C;
Hortobagyi, T;
Hoglund, K;
Aarsland, D;
... Hye, A; + view all
(2019)
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Acta Neuropathologica Communications
, 7
, Article 5. 10.1186/s40478-018-0649-3.
|
|
|
Ashton, NJ;
Nevado-Holgado, AJ;
Barber, IS;
Lynham, S;
Gupta, V;
Chatterjee, P;
Goozee, K;
... Hye, A; + view all
(2019)
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Science Advances
, 5
(2)
, Article eaau7220. 10.1126/sciadv.aau7220.
|
|
|
Ashton, NJ;
Suárez-Calvet, M;
Heslegrave, A;
Hye, A;
Razquin, C;
Pastor, P;
Sanchez-Valle, R;
... Zetterberg, H; + view all
(2019)
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Alzheimer's Research & Therapy
, 11
, Article 94. 10.1186/s13195-019-0545-5.
|
|
B
|
Babulal, GM;
Quiroz, YT;
Albensi, BC;
Arenaza-Urquijo, E;
Astell, AJ;
Babiloni, C;
Bahar-Fuchs, A;
... International Society to Advance Alzheimer's Research and Treatm, .; + view all
(2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimer's and Dementia
, 15
(2)
pp. 292-312.
10.1016/j.jalz.2018.09.009.
|
|
|
Baker, E;
Sims, R;
Leonenko, G;
Frizzati, A;
Harwood, JC;
Grozeva, D;
GERAD/PERADES, .;
... Escott-Price, V; + view all
(2019)
Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer's disease.
PLoS One
, 14
(7)
, Article e0218111. 10.1371/journal.pone.0218111.
|
|
|
Balendra, R;
Al Khleifat, A;
Fang, T;
Al-Chalabi, A;
(2019)
A standard operating procedure for King's ALS clinical staging.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
, 20
(3-4)
pp. 159-164.
10.1080/21678421.2018.1556696.
|
|
Bandres-Ciga, S;
Ahmed, S;
Sabir, MS;
Blauwendraat, C;
Adarmes-Gomez, AD;
Bernal-Bernal, I;
Bonilla-Toribio, M;
... Singleton, A; + view all
(2019)
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight.
Movement Disorders
10.1002/mds.27864.
(In press).
|
|
Bandres-Ciga, S;
Noyce, AJ;
Hemani, G;
Nicolas, A;
Calvo, A;
Mora, G;
Tienari, PJ;
... Traynor, BJ; + view all
(2019)
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis.
Annals of Neurology
, 85
(4)
pp. 470-481.
10.1002/ana.25431.
|
|
Bandres-Ciga, S;
Saez-Atienzar, S;
Bonet-Ponce, L;
Billingsley, K;
Vitale, D;
Blauwendraat, C;
Gibbs, JR;
... Singleton, AB; + view all
(2019)
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.
Movement Disorders
, 34
(4)
pp. 460-468.
10.1002/mds.27614.
|
|
Banerjee, G;
Adams, ME;
Jaunmuktane, Z;
Lammie, GA;
Turner, B;
Wani, M;
Sawhney, IMS;
... Werring, DJ; + view all
(2019)
Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura.
Annals of Neurology
, 85
(2)
pp. 284-290.
10.1002/ana.25407.
|
|
|
Bateman, R;
Blennow, K;
Doody, R;
Hendrix, S;
Lovestone, S;
Salloway, S;
Schindler, R;
... Zetterberg, H; + view all
(2019)
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report.
The Journal of Prevention of Alzheimer's Disease
, 6
(3)
pp. 169-173.
10.14283/jpad.2019.21.
|
|
Bendlin, BB;
Zetterberg, H;
(2019)
Screening with a high precision blood-based assay for Alzheimer disease.
[Editorial comment].
Neurology
10.1212/WNL.0000000000008080.
(In press).
|
|
Benedet, AL;
Ashton, NJ;
Pascoal, TA;
Leuzy, A;
Mathotaarachchi, S;
Kang, MS;
Therriault, J;
... Neto, PR; + view all
(2019)
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 679-689.
10.1016/j.dadm.2019.08.002.
|
|
|
Bernick, C;
Shan, G;
Zetterberg, H;
Banks, S;
Mishra, VR;
Bekris, L;
Leverenz, JB;
(2019)
Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Neurology
10.1212/WNL.0000000000008817.
(In press).
|
|
|
Bhattacharjee, P;
Öhrfelt, A;
Lashley, T;
Blennow, K;
Brinkmalm, A;
Zetterberg, H;
(2019)
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
Journal of Proteome Research
, 18
(5)
pp. 2109-2120.
10.1021/acs.jproteome.8b00982.
|
|
Bhome, R;
Huntley, JD;
Price, G;
Howard, RJ;
(2019)
Clinical presentation and neuropsychological profiles of Functional Cognitive Disorder patients with and without co-morbid depression.
Cognitive Neuropsychiatry
, 24
(2)
pp. 152-164.
10.1080/13546805.2019.1590190.
|
|
Bhome, R;
McWilliams, A;
Huntley, JD;
Fleming, SM;
Howard, RJ;
(2019)
Metacognition in functional cognitive disorder- a potential mechanism and treatment target.
Cognitive Neuropsychiatry
, 24
(5)
pp. 311-321.
10.1080/13546805.2019.1651708.
|
|
Billingsley, KJ;
Barbosa, IA;
Bandrés-Ciga, S;
Quinn, JP;
Bubb, VJ;
Deshpande, C;
Botia, JA;
... Koks, S; + view all
(2019)
Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset.
npj Parkinson's Disease
, 5
, Article 8. 10.1038/s41531-019-0080-x.
|
|
|
Blauwendraat, C;
Heilbron, K;
Vallerga, CL;
Bandres-Ciga, S;
von Coelln, R;
Pihlstrøm, L;
Simón-Sánchez, J;
... International Parkinson's Disease Genomics Consortium (IPDGC); + view all
(2019)
Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms.
Movement Disorders
10.1002/mds.27659.
(In press).
|
|
Blennow, K;
Diaz-Lucena, D;
Zetterberg, H;
Villar-Pique, A;
Karch, A;
Vidal, E;
Hermann, P;
... Llorens, F; + view all
(2019)
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2018-320155.
(In press).
|
|
|
Bocchetta, M;
Iglesias, JE;
Cash, DM;
Warren, JD;
Rohrer, JD;
(2019)
Amygdala subnuclei are differentially affected in the different genetic and pathological forms of frontotemporal dementia.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 136-141.
10.1016/j.dadm.2018.12.006.
(In press).
|
|
|
Bocchetta, M;
Iglesias, JE;
Chelban, V;
Jabbari, E;
Lamb, R;
Russell, LL;
Greaves, CV;
... Rohrer, JD; + view all
(2019)
Automated Brainstem Segmentation Detects Differential Involvement in Atypical Parkinsonian Syndromes.
Journal of Movement Disorders
10.14802/jmd.19030.
(In press).
|
|
|
Bocchetta, M;
Iglesias, JE;
Russell, L;
Greaves, CV;
Marshall, C;
Scelsi, MA;
Cash, D;
... Rohrer, J; + view all
(2019)
Segmentation of medial temporal subregions reveals early right-sided involvement in semantic variant PPA.
Alzheimer's Research and Therapy
, 11
, Article 41. 10.1186/s13195-019-0489-9.
|
|
|
Bonham, LW;
Steele, NZR;
Karch, CM;
Broce, I;
Geier, EG;
Wen, NL;
Momeni, P;
... International FTD-Genomics Consortium (IFGC), .; + view all
(2019)
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.
Scientific Reports
, 9
, Article 10854. 10.1038/s41598-019-46415-1.
|
|
|
Bonvicini, C;
Scassellati, C;
Benussi, L;
Di Maria, E;
Maj, C;
Ciani, M;
Fostinelli, S;
... Gennarelli, M; + view all
(2019)
Next Generation Sequencing Analysis in Early Onset Dementia Patients.
Journal of Alzheimer's Disease
, 67
(1)
pp. 243-256.
10.3233/JAD-180482.
|
|
|
Bos, I;
Vos, S;
Verhey, F;
Scheltens, P;
Teunissen, C;
Engelborghs, S;
Sleegers, K;
... Visser, PJ; + view all
(2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimer's & Dementia
, 15
(5)
pp. 644-654.
10.1016/j.jalz.2019.01.004.
|
|
Bowen, M;
Zutshi, H;
Cordiner, M;
Crutch, S;
Shakespeare, T;
(2019)
Qualitative, exploratory pilot study to investigate how people living with posterior cortical atrophy, their carers and clinicians experience tests used to assess vision.
BMJ Open
, 9
(3)
, Article e020905. 10.1136/bmjopen-2017-020905.
|
|
|
Brandner, S;
Jaunmuktane, Z;
(2019)
IDH mutant astrocytoma: biomarkers for prognostic stratification and the next frontiers.
[Editorial comment].
Neuropathology and Applied Neurobiology
, 45
(2)
pp. 91-94.
10.1111/nan.12521.
|
|
Bridel, C;
van Wieringen, WN;
Zetterberg, H;
Tijms, BM;
Teunissen, CE;
and the NFL Group;
Alvarez-Cermeño, JC;
... Wild, EJ; + view all
(2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurology
10.1001/jamaneurol.2019.1534.
(In press).
|
|
Brinkmalm, A;
Öhrfelt, A;
Bhattacharjee, P;
Zetterberg, H;
(2019)
Detection of α-Synuclein in Biological Samples Using Mass Spectrometry.
In:
Alpha-Synuclein Methods and Protocols.
(pp. 209-220).
Humana Press: New York, NY, USA.
|
|
Brinkmalm, A;
Portelius, E;
Brinkmalm, G;
Pannee, J;
Dahlén, R;
Gobom, J;
Blennow, K;
(2019)
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.
Journal of Neurochemistry
, 151
(4)
pp. 417-434.
10.1111/jnc.14594.
|
|
Brinkmalm, G;
Hong, W;
Wang, Z;
Liu, W;
O'Malley, TT;
Sun, X;
Frosch, MP;
... Walsh, DM; + view all
(2019)
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.
Brain
, 142
(5)
pp. 1441-1457.
10.1093/brain/awz066.
|
|
Brogueira Rodrigues, F;
Ferreira, JJ;
Wild, EJ;
(2019)
Huntington’s Disease Clinical Trials Corner: June 2019.
Journal of Huntington's disease
, 8
(3)
pp. 363-371.
10.3233/JHD-199003.
|
|
|
Brogueira Rodrigues, F;
Quinn, L;
Wild, E;
(2019)
Huntington's Disease Clinical Trials Corner: January 2019.
Journal of Huntington's Disease
, 8
(1)
pp. 115-125.
10.3233/JHD-190001.
|
|
|
Brogueira Rodrigues, FA;
Byrne, L;
De Vita, E;
Johnson, E;
Hobbs, N;
Thornton, J;
Scahill, R;
(2019)
Cerebrospinal fluid flow dynamics in Huntington's disease evaluated by phase contrast MRI.
European Journal of Neuroscience
10.1111/ejn.14356.
(In press).
|
|
Bruno, D;
Gleason, CE;
Koscik, RL;
Pomara, N;
Zetterberg, H;
Blennow, K;
Johnson, SC;
(2019)
The recency ratio is related to CSF amyloid beta 1‐42 levels in MCI‐AD.
International Journal of Geriatric Psychiatry
, 34
(3)
pp. 415-419.
10.1002/gps.5029.
|
|
Bugiardini, E;
Pope, S;
Feichtinger, RG;
Poole, OV;
Pittman, AM;
Woodward, CE;
Heales, S;
... Pitceathly, RDS; + view all
(2019)
Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related Diseases.
Journal Of Clinical Medicine
, 8
(7)
, Article 991. 10.3390/jcm8070991.
|
|
C
|
Cali, CP;
Patino, M;
Tai, YK;
Ho, WY;
McLean, CA;
Morris, CM;
Seeley, WW;
... Lee, EB; + view all
(2019)
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.
Acta Neuropathologica
, 138
(5)
pp. 795-811.
10.1007/s00401-019-02045-5.
|
|
Canas, LS;
Sudre, CH;
De Vita, E;
Nihat, A;
Mok, TH;
Slattery, CF;
Paterson, RW;
... Modat, M; + view all
(2019)
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
NeuroImage: Clinical
, Article 102051. 10.1016/j.nicl.2019.102051.
(In press).
|
|
|
Chatterjee, P;
Elmi, M;
Goozee, K;
Shah, T;
Sohrabi, HR;
Dias, CB;
Pedrini, S;
... Martins, RN; + view all
(2019)
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 71
(3)
pp. 775-783.
10.3233/JAD-190533.
|
|
|
Chatterjee, P;
Zetterberg, H;
Goozee, K;
Lim, CK;
Jacobs, KR;
Ashton, NJ;
Hye, A;
... Martins, RN; + view all
(2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Journal of Neuroinflammation
, 16
, Article 2019. 10.1186/s12974-019-1567-4.
|
|
|
Chaudhury, S;
Brookes, KJ;
Patel, T;
Fallows, A;
Guetta-Baranes, T;
Turton, JC;
Guerreiro, R;
... Thomas, AJ; + view all
(2019)
Alzheimer's disease polygenic risk score as a predictor of conversion from mild-cognitive impairment.
Translational Psychiatry
, 9
, Article 154. 10.1038/s41398-019-0485-7.
|
|
|
Chelban, V;
Bocchetta, M;
Hassanein, S;
Haridy, NA;
Houlden, H;
Rohrer, JD;
(2019)
An update on advances in magnetic resonance imaging of multiple system atrophy.
Journal of Neurology
, 266
(4)
pp. 1036-1045.
10.1007/s00415-018-9121-3.
|
|
|
Chelban, V;
Wilson, MP;
Warman Chardon, J;
Vandrovcova, J;
Zanetti, MN;
Zamba-Papanicolaou, E;
Efthymiou, S;
... SYNaPS Study Group, .; + view all
(2019)
PDXK mutations cause polyneuropathy responsive to PLP supplementation.
Annals of Neurology
10.1002/ana.25524.
(In press).
|
|
|
Chen, Z;
et al, .;
(2019)
Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Movement Disorders
10.1002/mds.27702..
(In press).
|
|
Chen, Z;
Houlden, H;
Puzriakova, A;
(2019)
Spinocerebellar Ataxia Type 11.
GeneReviews
(In press).
|
|
|
Chen, Z;
Mengel, D;
Keshavan, A;
Rissman, RA;
Billinton, A;
Perkinton, M;
Percival-Alwyn, J;
... Walsh, DM; + view all
(2019)
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
Alzheimer's & Dementia
, 15
(3)
pp. 487-496.
10.1016/j.jalz.2018.09.010.
|
|
Cheng, SF;
Zarkali, A;
Richards, T;
Simister, R;
Chandratheva, A;
(2019)
Carotid artery stenosis, an underestimated cause of stroke recurrence in patients with ischaemic monocular visual loss.
Annals of the Royal College of Surgeons of England
, 101
(8)
pp. 579-583.
10.1308/rcsann.2019.0071.
|
|
Chew, B;
Hauser, TU;
Papoutsi, M;
Magerkurth, J;
Dolan, RJ;
Rutledge, RB;
(2019)
Endogenous fluctuations in the dopaminergic midbrain drive behavioral choice variability.
Proceedings of the National Academy of Sciences (PNAS)
10.1073/pnas.1900872116.
(In press).
|
|
|
Christopher, E;
Poon, MTC;
Glancz, LJ;
Hutchinson, PJ;
Kolias, AG;
Brennan, PM;
Afshari, FT;
... Zaben, M; + view all
(2019)
Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma.
Neurosurgical Review
, 42
(2)
427`-431.
10.1007/s10143-018-0979-4.
|
|
Cicognola, C;
Brinkmalm, G;
Wahlgren, J;
Portelius, E;
Gobom, J;
Cullen, NC;
Hansson, O;
... Höglund, K; + view all
(2019)
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
Acta Neuropathologica
10.1007/s00401-018-1948-2.
(In press).
|
|
|
Ciosi, M;
Maxwell, A;
Cumming, SA;
Hensman Moss, DJ;
Alshammari, AM;
Flower, MD;
Durr, A;
... Monckton, DG; + view all
(2019)
A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
EBioMedicine
10.1016/j.ebiom.2019.09.020.
(In press).
|
|
|
Clare, A;
Camic, PM;
Crutch, SJ;
West, J;
Harding, E;
Brotherhood, E;
(2019)
Using Music to Develop a Multisensory Communicative Environment for People with Late-Stage Dementia.
The Gerontologist
10.1093/geront/gnz169.
(In press).
|
|
|
Clarke, MTM;
Brinkmalm, A;
Foiani, MS;
Woollacott, IOC;
Heller, C;
Heslegrave, A;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.
Alzheimer's Research and Therapy
, 11
, Article 105. 10.1186/s13195-019-0564-2.
|
|
|
Cohen, AD;
Landau, SM;
Snitz, BE;
Klunk, WE;
Blennow, K;
Zetterberg, H;
(2019)
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
Molecular and Cellular Neuroscience
, 97
pp. 3-17.
10.1016/j.mcn.2018.12.004.
|
|
Convery, R;
Mead, S;
Rohrer, JD;
(2019)
Review: Clinical, genetic and neuroimaging features of frontotemporal dementia.
Neuropathology and Applied Neurobiology
, 45
(1)
pp. 6-18.
10.1111/nan.12535.
|
|
Convery, RS;
Jiao, J;
Clarke, MTM;
Moore, KM;
Koriath, CAM;
Woollacott, IOC;
Weston, PSJ;
... Rohrer, JD; + view all
(2019)
Longitudinal (¹⁸F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320904.
(In press).
|
|
Craven, CL;
Chapman, MD;
D'Antona, L;
Thompson, SD;
Lakdawala, N;
Zetterberg, H;
Watkins, LD;
(2019)
Lumbar drains can affect CSF biomarker levels.
[Letter].
Journal of Clinical Pathology
, 72
(1)
pp. 91-92.
10.1136/jclinpath-2018-205296.
|
|
|
Cunningham, EL;
McGuinness, B;
McAuley, DF;
Toombs, J;
Mawhinney, T;
O'Brien, S;
Beverland, D;
... Passmore, AP; + view all
(2019)
CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.
Annals of Surgery
, 269
(6)
pp. 1200-1205.
10.1097/SLA.0000000000002684.
|
|
Cury, C;
Durrleman, S;
Cash, DM;
Lorenzi, M;
Nicholas, JM;
Bocchetta, M;
van Swieten, JC;
... Genetic FTD Initiative, GENFI, .; + view all
(2019)
Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort.
Neuroimage
, 188
pp. 282-290.
10.1016/j.neuroimage.2018.11.063.
|
|
D
|
De, S;
Whiten, DR;
Ruggeri, FS;
Hughes, C;
Rodrigues, M;
Sideris, D;
Taylor, CG;
... Klenerman, D; + view all
(2019)
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.
Acta Neuropathologica Communications
, 7
, Article 120. 10.1186/s40478-019-0777-4.
|
|
|
de Flon, P;
Laurell, K;
Sundström, P;
Blennow, K;
Söderström, L;
Zetterberg, H;
Gunnarsson, M;
(2019)
Comparison of plasma and CSF Neurofilament-light in an MS trial.
Acta Neurologica Scandinavica
, 139
(5)
pp. 462-468.
10.1111/ane.13078.
|
|
De Francesco, D;
Choi, J-P;
Choi, JY;
van Zoest, RA;
Underwood, J;
Schouten, J;
Ku, NS;
... van Zoest, RA; + view all
(2019)
Cognitive function and drivers of cognitive impairment in a European and a Korean cohort of people living with HIV.
International Journal of STD & AIDS
10.1177/0956462419881080.
(In press).
|
|
|
De Francesco, D;
Wit, FW;
Bürkle, A;
Oehlke, S;
Kootstra, NA;
Winston, A;
Franceschi, C;
... The Co-morBidity in Relation to AIDS (COBRA) Collaboration, .; + view all
(2019)
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
AIDS
, 33
(2)
pp. 259-268.
10.1097/QAD.0000000000002063.
|
|
Deisenhammer, F;
Zetterberg, H;
Fitzner, B;
Zettl, UK;
(2019)
The Cerebrospinal Fluid in Multiple Sclerosis.
[Review].
Frontiers in Immunology
, 10
, Article 726. 10.3389/fimmu.2019.00726.
|
|
|
Delsing, L;
Kallur, T;
Zetterberg, H;
Hicks, R;
Synnergren, J;
(2019)
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.
Fluids and Barriers of the CNS
, 16
, Article 27. 10.1186/s12987-019-0147-4.
|
|
|
DeMarshall, C;
Oh, E;
Kheirkhah, R;
Sieber, F;
Zetterberg, H;
Blennow, K;
Nagele, RG;
(2019)
Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
PLoS One
, 14
(11)
, Article e0225178. 10.1371/journal.pone.0225178.
|
|
|
Demetriou, E;
Tachrount, M;
Ellis, M;
LINEHAN, J;
Brandner, S;
Shmueli, K;
Farrow, M;
(2019)
A multiparametric study of prion disease.
In:
Proceedings of the ISMRM 27th Annual Meeting & Exhibition 2019.
(pp. p. 2613).
ISMRM: Montréal, QC, Canada.
|
|
Deming, Y;
Filipello, F;
Cignarella, F;
Cantoni, C;
Hsu, S;
Mikesell, R;
Li, Z;
... Cruchaga, C; + view all
(2019)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
Science Translational Medicine
, 11
(505)
, Article eaau2291. 10.1126/scitranslmed.aau2291.
|
|
den Haan, J;
Csinscik, L;
Parker, T;
Paterson, RW;
Slattery, CF;
Foulkes, A;
Bouwman, FH;
... Yong, KXX; + view all
(2019)
Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.
Alzheimer's Research and Therapy
, 11
, Article 62. 10.1186/s13195-019-0516-x.
|
|
|
Desmarais, P;
Rohrer, JD;
Nguyen, QD;
Herrmann, N;
Stuss, DT;
Lang, AE;
Boxer, AL;
... Masellis, M; + view all
(2019)
Therapeutic trial design for frontotemporal dementia and related disorders.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-318603.
(In press).
|
|
|
Dhiman, K;
Blennow, K;
Zetterberg, H;
Martins, RN;
Gupta, VB;
(2019)
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
Cellular and Molecular Life Sciences
, 76
pp. 1833-1863.
10.1007/s00018-019-03040-5.
|
|
Duarte, GS;
Nunes-Ferreira, A;
Brogueira Rodrigues, F;
Pinto, F;
Ferreira, JJ;
Costa, J;
Caldeira, D;
(2019)
Morphine in acute coronary syndrome: systematic review and meta-analysis.
BMJ Open
, 9
(3)
, Article e025232. 10.1136/bmjopen-2018-025232.
|
|
Dube, U;
Del-Aguila, JL;
Li, Z;
Budde, JP;
Jiang, S;
Hsu, S;
Ibanez, L;
... Xu, X; + view all
(2019)
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Nature Neuroscience
, 22
pp. 1903-1912.
10.1038/s41593-019-0501-5.
|
|
Dumitrescu, L;
Barnes, LL;
Thambisetty, M;
Beecham, G;
Kunkle, B;
Bush, WS;
Gifford, KA;
... Hohman, TJ; + view all
(2019)
Sex differences in the genetic predictors of Alzheimer's pathology.
Brain
, 142
(9)
pp. 2581-2589.
10.1093/brain/awz206.
|
E
|
Efthymiou, S;
Salpietro, V;
Malintan, N;
Poncelet, M;
Kriouile, Y;
Fortuna, S;
De Zorzi, R;
... Houlden, H; + view all
(2019)
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination.
Brain
10.1093/brain/awz248.
(In press).
|
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
Correction: The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(2)
, Article e0212830. 10.1371/journal.pone.0212830.
|
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(1)
, Article e0211184. 10.1371/journal.pone.0211184.
|
|
|
Erickson, CM;
Schultz, SA;
Oh, JM;
Darst, BF;
Ma, Y;
Norton, D;
Betthauser, T;
... Okonkwo, OC; + view all
(2019)
KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.
Neurology
10.1212/WNL.0000000000007323.
(In press).
|
|
Escott-Price, V;
Baker, E;
Shoai, M;
Leonenko, G;
Myers, AJ;
Huentelman, M;
Hardy, J;
(2019)
Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls.
Neurobiology of Aging
, 77
pp. 178-182.
10.1016/j.neurobiolaging.2018.12.002.
|
|
Escott-Price, V;
Myers, A;
Huentelman, M;
Shoai, M;
Hardy, J;
(2019)
Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles.
The Journal of Prevention of Alzheimer’s Disease
, 6
(1)
pp. 16-19.
10.14283/jpad.2018.46.
|
|
|
Estevez-Fraga, C;
Johnson, E;
Rodrigues, F;
Zeun, P;
Durr, A;
Langbehn, D;
Leavitt, B;
... TrackHD investigators; + view all
(2019)
Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington's disease gene carriers.
Presented at: International Congress of the Parkinson's Disease and Movement Disorders, Nice, France.
|
F
|
Femminella, GD;
Frangou, E;
Love, SB;
Busza, G;
Holmes, C;
Ritchie, C;
Lawrence, R;
... Edison, P; + view all
(2019)
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Trials
, 20
, Article 191. 10.1186/s13063-019-3259-x.
|
|
|
Firth, NC;
Primativo, S;
Marinescu, R-V;
Shakespeare, TJ;
Suarez-Gonzalez, A;
Lehmann, M;
Carton, A;
... Crutch, SJ; + view all
(2019)
Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.
Brain
, 142
(7)
pp. 2082-2095.
10.1093/brain/awz136.
|
|
|
Fisher, CK;
Smith, AM;
Walsh, JR;
Simone, AJ;
Edgar, C;
Jack, CR;
Holtzman, D;
... Kubick, W; + view all
(2019)
Machine learning for comprehensive forecasting of Alzheimer's Disease progression.
Scientific Reports
, 9
, Article 13622. 10.1038/s41598-019-49656-2.
|
|
|
Flower, M;
Lomeikaite, V;
Ciosi, M;
Cumming, S;
Morales, F;
Lo, K;
Hensman Moss, D;
... Tabrizi, SJ; + view all
(2019)
MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1.
Brain
, 142
(7)
pp. 1876-1886.
10.1093/brain/awz115.
|
|
|
Flower, Michael;
(2019)
Genetic variation in DNA repair proteins modifies the course of Huntington’s disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Foiani, MS;
Cicognola, C;
Ermann, N;
Woollacott, IOC;
Heller, C;
Heslegrave, AJ;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-319266.
(In press).
|
|
|
Forsberg, M;
Seth, H;
Björefeldt, A;
Lyckenvik, T;
Andersson, M;
Wasling, P;
Zetterberg, H;
(2019)
Ionized calcium in human cerebrospinal fluid and its influence on intrinsic and synaptic excitability of hippocampal pyramidal neurons in the rat.
Journal of Neurochemistry
, 149
(4)
pp. 452-470.
10.1111/jnc.14693.
|
|
Fossati, S;
Ramos Cejudo, J;
Debure, L;
Pirraglia, E;
Sone, JY;
Li, Y;
Chen, J;
... de Leon, MJ; + view all
(2019)
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 483-492.
10.1016/j.dadm.2019.05.001.
(In press).
|
|
|
Foti, S;
Hargreaves, I;
Carrington, S;
Kiely, AP;
Houlden, H;
Holton, J;
(2019)
Cerebral mitochondrial electron transport chain dysfunction in multiple system atrophy and Parkinson’s disease.
Scientific Reports
, 9
, Article 6559. 10.1038/s41598-019-42902-7.
|
|
|
Frankel, R;
Törnquist, M;
Meisl, G;
Hansson, O;
Andreasson, U;
Zetterberg, H;
Blennow, K;
... Linse, S; + view all
(2019)
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid.
Communications Biology
, 2
, Article 365. 10.1038/s42003-019-0612-2.
|
|
|
Frisoni, GB;
Barkhof, F;
Altomare, D;
Berkhof, J;
Boccardi, M;
Canzoneri, E;
Collij, L;
... Raffa, N; + view all
(2019)
AMYPAD Diagnostic and Patient Management Study: Rationale and Design.
Alzheimer's & Dementia
, 15
(3)
pp. 388-399.
10.1016/j.jalz.2018.09.003.
|
|
G
|
Gaetani, L;
Blennow, K;
Calabresi, P;
Di Filippo, M;
Parnetti, L;
Zetterberg, H;
(2019)
Neurofilament light chain as a biomarker in neurological disorders.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(8)
pp. 870-881.
10.1136/jnnp-2018-320106.
|
|
|
Gaetani, L;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
Parnetti, L;
Calabresi, P;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 35
pp. 228-232.
10.1016/j.msard.2019.07.025.
|
|
Gaetani, L;
Salvadori, N;
Lisetti, V;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Journal of Neurology
, 266
pp. 2157-2163.
10.1007/s00415-019-09398-7.
|
|
Gafson, AR;
Savva, C;
Thorne, T;
David, M;
Gomez-Romero, M;
Lewis, MR;
Nicholas, R;
... Matthews, PM; + view all
(2019)
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.
Neurology: Neuroimmunology & NeuroInflammation
, 6
(3)
, Article e562. 10.1212/NXI.0000000000000562.
|
|
Garbarino, S;
Lorenzi, M;
Oxtoby, NP;
Vinke, EJ;
Marinescu, RV;
Eshaghi, A;
Ikram, MA;
... Alexander, DC; + view all
(2019)
Differences in topological progression profile among neurodegenerative diseases from imaging data.
eLife
, 8
10.7554/eLife.49298.
(In press).
|
|
|
Gatenholm, B;
Gobom, J;
Skillbäck, T;
Blennow, K;
Zetterberg, H;
Brittberg, M;
(2019)
Peptidomic Analysis of Cartilage and Subchondral bone in OA patients.
European Journal of Clinical Investigation
, 49
(5)
, Article e13082. 10.1111/eci.13082.
|
|
Gazzina, S;
Grassi, M;
Premi, E;
Cosseddu, M;
Alberici, A;
Archetti, S;
Gasparotti, R;
... Genetic FTD Initiative, GENFI, .; + view all
(2019)
Education modulates brain maintenance in presymptomatic frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2019-320439.
(In press).
|
|
|
Ghasemi, DR;
Sill, M;
Okonechnikov, K;
Korshunov, A;
Yip, S;
Schutz, PW;
Scheie, D;
... Pajtler, KW; + view all
(2019)
MYCN amplification drives an aggressive form of spinal ependymoma.
Acta Neuropathologica
, 138
pp. 1075-1089.
10.1007/s00401-019-02056-2.
|
|
|
Gisslen, M;
Heslegrave, A;
Veleva, E;
Yilmaz, A;
Andersson, L-M;
Hagberg, L;
Spudich, S;
... Zetterberg, H; + view all
(2019)
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
Neurology, Neuroimmunology and Neuroinflammation
, 6
(1)
, Article e512. 10.1212/NXI.0000000000000512.
|
|
|
Gittings, LM;
Boeynaems, S;
Lightwood, D;
Clargo, A;
Topia, S;
Nakayama, L;
Troakes, C;
... Isaacs, AM; + view all
(2019)
Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity.
Acta Neuropathologica
10.1007/s00401-019-02104-x.
(In press).
|
|
|
Gittings, LM;
Foti, SC;
Benson, BC;
Gami-Patel, P;
Isaacs, AM;
Lashley, T;
(2019)
Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.
Acta Neuropathol Commun
, 7
(1)
, Article 18. 10.1186/s40478-019-0673-y.
|
|
|
Gkanatsiou, E;
Portelius, E;
Toomey, CE;
Blennow, K;
Zetterberg, H;
Lashley, T;
Brinkmalm, G;
(2019)
A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Neuroscience Letters
, 701
pp. 125-131.
10.1016/j.neulet.2019.02.033.
|
|
González, AS;
Hoffman, P;
Crutch, S;
(2019)
Where words meet numbers: Comprehension of measurement unit terms in posterior cortical atrophy.
Neuropsychologia
, 131
pp. 216-222.
10.1016/j.neuropsychologia.2019.05.004.
|
|
Gorgoraptis, N;
Li, LM;
Whittington, A;
Zimmerman, KA;
Maclean, LM;
McLeod, C;
Ross, E;
... Sharp, DJ; + view all
(2019)
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.
Science Translational Medicine
, 11
(508)
, Article eaaw1993. 10.1126/scitranslmed.aaw1993.
|
|
|
Grand, J;
Kjaergaard, J;
Nielsen, N;
Friberg, H;
Cronberg, T;
Bro-Jeppesen, J;
Karsdal, MA;
... Hassager, C; + view all
(2019)
Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest.
Biomarkers
, 24
(6)
pp. 584-591.
10.1080/1354750X.2019.1609580.
|
|
Greaves, CV;
Rohrer, JD;
(2019)
An update on genetic frontotemporal dementia.
Journal of Neurology
, 266
(8)
pp. 2075-2086.
10.1007/s00415-019-09363-4.
|
|
Gregory, S;
Odish, OFF;
Mayer, I;
Mills, J;
Johnson, EB;
Scahill, RI;
Rothwell, J;
... Orth, M; + view all
(2019)
Multimodal characterization of the visual network in Huntington's disease gene carriers.
Clinical Neurophysiology
, 130
(11)
pp. 2053-2059.
10.1016/j.clinph.2019.08.018.
|
|
Guelfi, S;
Botia, JA;
Thom, M;
Ramasamy, A;
Perona, M;
Stanyer, L;
Martinian, L;
... Matarin, M; + view all
(2019)
Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy.
Brain
, 142
(6)
pp. 1616-1630.
10.1093/brain/awz074.
|
|
Guerreiro, R;
Escott-Price, V;
Hernandez, DG;
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Neto, JL;
... Bras, J; + view all
(2019)
Heritability and genetic variance of dementia with Lewy bodies.
Neurobiology of Disease
, 127
pp. 492-501.
10.1016/j.nbd.2019.04.004.
|
|
Guerreiro, R;
Orme, T;
Naj, AC;
Kuzma, AB;
Schellenberg, GD;
Bras, J;
(2019)
Is APOE ε4 required for Alzheimer's disease to develop in TREM2 p.R47H variant carriers?
[Letter].
Neuropathology and Applied Neurobiology
, 45
(2)
pp. 187-189.
10.1111/nan.12517.
|
|
Guven, G;
Bilgic, B;
Tufekcioglu, Z;
Erginel Unaltuna, N;
Hanagasi, H;
Gurvit, H;
Singleton, A;
... Lohmann, E; + view all
(2019)
Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia.
Journal of Alzheimer's Disease
, 67
(1)
pp. 159-167.
10.3233/JAD-180599.
|
|
H
|
Habib, A;
Okorokov, A;
Hill, M;
Bras, J;
Lee, M-C;
Li, S;
Gossage, S;
... Cox, J; + view all
(2019)
Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity.
British Journal of Anaesthesia
, 123
(2)
e249-e253.
10.1016/j.bja.2019.02.019.
|
|
|
Hall, S;
Janelidze, S;
Zetterberg, H;
Brix, B;
Mattsson, N;
Surova, Y;
Blennow, K;
(2019)
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Movement Disorders
10.1002/mds.27950.
(In press).
|
|
Hansen, D;
Ling, H;
Lashley, T;
Holton, J;
Warner, T;
(2019)
Clinical, neuropathological and genetic features of Lewy body dementias.
Neuropathology and Applied Neurobiology
, 45
(7)
pp. 635-654.
10.1111/nan.12554.
|
|
Hansson, K;
Dahlen, R;
Hansson, O;
Pernevik, E;
Paterson, R;
Schott, JM;
Magdalinou, N;
... Gobom, J; + view all
(2019)
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.
Clinical Mass Spectrometry
, 14
(Part B)
pp. 74-82.
10.1016/j.clinms.2019.07.002.
|
|
Hansson, O;
Lehmann, S;
Otto, M;
Zetterberg, H;
Lewczuk, P;
(2019)
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Alzheimer's Research & Therapy
, 11
, Article 34. 10.1186/s13195-019-0485-0.
|
|
|
Hardy, CJD;
Frost, C;
Sivasathiaseelan, H;
Johnson, JCS;
Agustus, JL;
Bond, RL;
Benhamou, E;
... Warren, JD; + view all
(2019)
Findings of Impaired Hearing in Patients With Nonfluent/Agrammatic Variant Primary Progressive Aphasia.
JAMA Neurology
10.1001/jamaneurol.2018.4799.
(In press).
|
|
|
Hardy, CJD;
Johnson, JCS;
Warren, JD;
(2019)
Auditory symptoms in primary progressive aphasia: A commentary on Utianski et al. (2019).
Cortex
, 119
pp. 580-582.
10.1016/j.cortex.2019.03.023.
|
|
Hardy, J;
(2019)
Failures in Protein Clearance Partly Underlie Late Onset Neurodegenerative Diseases and Link Pathology to Genetic Risk.
Frontiers in Neuroscience
, 13
, Article 1304. 10.3389/fnins.2019.01304.
|
|
|
Hardy, J;
Escott-Price, V;
(2019)
Genes, pathways and risk prediction in Alzheimer's disease.
Human Molecular Genetics
, 28
(R2)
R235-R240.
10.1093/hmg/ddz163.
|
|
Harrison, IF;
Whitaker, R;
Bertelli, PM;
O'Callaghan, JM;
Csincsik, L;
Bocchetta, M;
Ma, D;
... Lengyel, I; + view all
(2019)
Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.
Acta Neuropathologica Communications
, 7
, Article 4. 10.1186/s40478-018-0654-6.
|
|
Hasselgren, C;
Ekbrand, H;
Fässberg, MM;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2019)
APOE ε₄ and the long arm of social inequity: estimated effects of socio-economic status and sex on the timing of dementia onset.
Ageing & Society
, 39
(9)
pp. 1951-1975.
10.1017/S0144686X18000351.
|
|
|
Hedberg-Oldfors, C;
Abramsson, A;
Osborn, DPS;
Danielsson, O;
Fazlinezhad, A;
Nilipour, Y;
Hübbert, L;
... Jamshidi, Y; + view all
(2019)
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24.
Human Molecular Genetics
, 28
(11)
pp. 1919-1929.
10.1093/hmg/ddz032.
|
|
Heinzel, S;
Berg, D;
Gasser, T;
Chen, H;
Yao, C;
Postuma, RB;
Adler, CH;
... Stern, M; + view all
(2019)
Update of the MDS research criteria for prodromal Parkinson's disease.
Movement Disorders
, 34
(10)
pp. 1464-1470.
10.1002/mds.27802.
|
|
|
Hepner, A;
Porter, J;
Hare, F;
Nasir, SS;
Zetterberg, H;
Blennow, K;
Martin, MG;
(2019)
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas.
World Journal of Oncology
, 10
(4-5)
pp. 169-175.
10.14740/wjon1228.
|
|
|
Hermansson, L;
Yilmaz, A;
Axelsson, M;
Blennow, K;
Fuchs, D;
Hagberg, L;
Lycke, J;
... Gisslén, M; + view all
(2019)
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
Journal of Neuroinflammation
, 16
, Article 16. 10.1186/s12974-019-1404-9.
|
|
|
Hermansson, L;
Yilmaz, A;
Price, RW;
Nilsson, S;
McCallister, S;
Makadzange, T;
Das, M;
... Gisslen, M; + view all
(2019)
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
PLOS ONE
, 14
(12)
, Article e0226276. 10.1371/journal.pone.0226276.
|
|
|
Hett, K;
Ta, V-T;
Catheline, G;
Tourdias, T;
Manjón, JV;
Coupé, P;
Alzheimer’s Disease Neuroimaging Initiative;
(2019)
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification.
Scientific Reports
, 9
, Article 13845. 10.1038/s41598-019-49970-9.
|
|
|
Heurling, K;
Ashton, NJ;
Leuzy, A;
Zimmer, ER;
Blennow, K;
Zetterberg, H;
Eriksson, J;
... Schöll, M; + view all
(2019)
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2019.02.001.
(In press).
|
|
|
Hithersay, R;
Startin, CM;
Hamburg, S;
Mok, KY;
Hardy, J;
Fisher, EMC;
Tybulewicz, VLJ;
... Strydom, A; + view all
(2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.
JAMA Neurology
, 76
(2)
pp. 152-160.
10.1001/jamaneurol.2018.3616.
|
|
|
Höglund, K;
Schussler, N;
Kvartsberg, H;
Smailovic, U;
Brinkmalm, G;
Liman, V;
Becker, B;
... Blennow, K; + view all
(2019)
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.
Neurobiology of Disease
, 134
, Article 104645. 10.1016/j.nbd.2019.104645.
|
|
|
Holmøy, T;
Røsjø, E;
Zetterberg, H;
Blennow, K;
Lindstrøm, JC;
Steffensen, LH;
Kampman, MT;
(2019)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
Acta Neurologica Scandinavica
, 139
(2)
pp. 172-176.
10.1111/ane.13037.
|
|
Horga, A;
Bugiardini, E;
Manole, A;
Bremner, F;
Jaunmuktane, Z;
Dankwa, L;
Rebelo, AP;
... Reilly, MM; + view all
(2019)
Autosomal dominant optic atrophy and cataract “plus” phenotype including axonal neuropathy.
Neurology: Genetics
, 5
(2)
, Article e322. 10.1212/NXG.0000000000000322.
|
|
|
Hossain, I;
Mohammadian, M;
Takala, RS;
Tenovuo, O;
Lagerstedt, L;
Ala-Seppälä, HM;
Frantzén, J;
... Posti, JP; + view all
(2019)
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
Journal of Neurotrauma
, 36
(10)
pp. 1551-1560.
10.1089/neu.2018.5952.
|
|
Hou, Y;
Pinheiro, J;
Sahm, F;
Reuss, DE;
Schrimpf, D;
Stichel, D;
Casalini, B;
... Bertero, L; + view all
(2019)
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Acta Neuropathologica
, 137
pp. 837-846.
10.1007/s00401-019-01969-2.
|
|
Hu, Y;
Li, M;
Lu, Q;
Weng, H;
Wang, J;
Zekavat, SM;
Yu, Z;
... Yu, L; + view all
(2019)
A statistical framework for cross-tissue transcriptome-wide association analysis.
Nature Genetics
, 51
(3)
pp. 568-576.
10.1038/s41588-019-0345-7.
|
|
Huentelman, M;
De Both, M;
Jepsen, W;
Piras, IS;
Talboom, JS;
Willeman, M;
Reiman, EM;
... Myers, AJ; + view all
(2019)
Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
Scientific Reports
, 9
, Article 9640. 10.1038/s41598-019-45896-4.
|
|
|
Hughes, CD;
Choi, ML;
Ryten, M;
Hopkins, L;
Drews, A;
Botía, JA;
Iljina, M;
... Klenerman, D; + view all
(2019)
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson's disease pathogenesis.
Acta Neuropathologica
, 137
(1)
pp. 103-120.
10.1007/s00401-018-1907-y.
|
|
|
Hyare, H;
Rice, L;
Thust, S;
Nachev, P;
Jha, A;
Milic, M;
Brandner, S;
(2019)
Modelling MR and clinical features in grade II/III astrocytomas to predict IDH mutation status.
European Journal of Radiology
, 114
pp. 120-127.
10.1016/j.ejrad.2019.03.003.
|
I
|
Irvine, EE;
Katsouri, L;
Plattner, F;
Al-Qassab, H;
Al-Nackkash, R;
Bates, GP;
Withers, DJ;
(2019)
Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's disease.
Scientific Reports
, 9
, Article 16133. 10.1038/s41598-019-52391-3.
|
|
|
Iverson, GL;
Reddi, PJ;
Posti, JP;
Kotilainen, A-K;
Tenovuo, O;
Öhman, J;
Zetterberg, H;
... Luoto, TM; + view all
(2019)
Serum Neurofilament Light is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries.
Journal of Neurotrauma
, 36
(16)
pp. 2400-2406.
10.1089/neu.2018.6341.
|
J
|
Jabbari, E;
Holland, N;
Chelban, V;
Jones, PS;
Lamb, R;
Rawlinson, C;
Guo, T;
... Morris, HR; + view all
(2019)
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
JAMA Neurology
, 77
(3)
pp. 377-387.
10.1001/jamaneurol.2019.4347.
|
|
|
Jabbari, E;
Woodside, J;
Guo, T;
Magdalinou, NK;
Chelban, V;
Athauda, D;
Lees, AJ;
... Morris, HR; + view all
(2019)
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-320151.
|
|
|
Jabbari, E;
Woodside, J;
Tan, MMX;
Pavese, N;
Bandmann, O;
Ghosh, BCP;
Massey, LA;
... Morris, HR; + view all
(2019)
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy.
Movement Disorders
10.1002/mds.27786.
(In press).
|
|
|
Jacobs, KR;
Lim, CK;
Blennow, K;
Zetterberg, H;
Chatterjee, P;
Martins, RN;
Brew, BJ;
... Lovejoy, DB; + view all
(2019)
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau.
Neurobiology of Aging
, 80
pp. 11-20.
10.1016/j.neurobiolaging.2019.03.015.
|
|
Jadhav, S;
Avila, J;
Schöll, M;
Kovacs, G;
Kövari, E;
Skrabana, R;
Evans, L;
... Zilka, N; + view all
(2019)
A walk through tau therapeutic strategies.
Acta Neuopathologica Communications
10.1186/s40478-019-0664-z.
|
|
|
Jansen, IE;
Savage, JE;
Watanabe, K;
Bryois, J;
Williams, DM;
Steinberg, S;
Sealock, J;
... Posthuma, D; + view all
(2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
Nature Genetics
, 51
pp. 404-413.
10.1038/s41588-018-0311-9.
|
 |
|
Jaunmuktane, Z;
Brandner, S;
(2019)
On the journey to uncover the causes of selective cellular and regional vulnerability in neurodegeneration.
Acta Neuropathologica
, 138
pp. 677-680.
10.1007/s00401-019-02079-9.
|
|
Jaunmuktane, Z;
Brandner, S;
(2019)
Transmissible human proteopathies: an expanding field.
Diagnostic Histopathology
, 25
(1)
pp. 16-22.
10.1016/j.mpdhp.2018.11.002.
|
|
Jaunmuktane, Z;
Capper, D;
Jones, DTW;
Schrimpf, D;
Sill, M;
Dutt, M;
Suraweera, N;
... Brandner, S; + view all
(2019)
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
Acta Neuropathologica Communications
, 7
, Article 24. 10.1186/s40478-019-0668-8.
|
|
|
Jensen, CS;
Bahl, JM;
Østergaard, LB;
Høgh, P;
Wermuth, L;
Heslegrave, A;
Zetterberg, H;
... Simonsen, AH; + view all
(2019)
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
Experimental Gerontology
, 121
pp. 91-98.
10.1016/j.exger.2019.04.003.
|
|
|
Jeppsson, A;
Wikkelsö, C;
Blennow, K;
Zetterberg, H;
Constantinescu, R;
Remes, AM;
Herukka, S-K;
... Tullberg, M; + view all
(2019)
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(10)
pp. 1117-1123.
10.1136/jnnp-2019-320826.
|
|
Joel, Z;
Izquierdo, P;
Salih, DA;
Richardson, JC;
Cummings, DM;
Edwards, FA;
(2019)
Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression?
Cold Spring Harbor Symposia on Quantitative Biology
, 83
pp. 151-161.
10.1101/sqb.2018.83.037531.
|
|
Johansson, L;
Sacuiu, S;
Kern, S;
Guo, X;
Zetterberg, H;
Blennow, K;
Zettergren, A;
(2019)
Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women.
Neurobiology of Aging
, 80
pp. 111-115.
10.1016/j.neurobiolaging.2019.02.013.
|
|
Johnson, EB;
Gregory, S;
(2019)
Brain imaging in Huntington's disease.
In:
Progress in Molecular Biology and Translational Science.
(pp. 321-369).
Elsevier: Amsterdam, The Netherlands.
|
|
Johnson, EB;
Scahill, RI;
Tabrizi, SJ;
(2019)
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images.
Journal of Visualized Experiments
, 143
, Article e58198. 10.3791/58198.
|
|
|
Jonaitis, EM;
Koscik, RL;
Clark, LR;
Ma, Y;
Betthauser, TJ;
Berman, SE;
Allison, SL;
... Johnson, SC; + view all
(2019)
Measuring longitudinal cognition: Individual tests versus composites.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 74-84.
10.1016/j.dadm.2018.11.006.
|
K
|
Kagiava, A;
Richter, J;
Tryfonos, C;
Karaiskos, C;
Heslegrave, AJ;
Sargiannidou, I;
Rossor, AM;
... Kleopa, KA; + view all
(2019)
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
Human Molecular Genetics
, 28
(21)
pp. 3528-3542.
10.1093/hmg/ddz199.
|
|
Kam, K;
Parekh, A;
Sharma, RA;
Andrade, A;
Lewin, M;
Castillo, B;
Bubu, OM;
... Osorio, RS; + view all
(2019)
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.
Molecular Neurodegeneration
, 14
, Article 10. 10.1186/s13024-019-0309-5.
|
|
|
Kapoor, M;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
Lunn, MP;
Malaspina, A;
Gillmore, JD;
... Reilly, MM; + view all
(2019)
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Journal of the Peripheral Nervous System
, 24
(4)
pp. 314-319.
10.1111/jns.12350.
|
|
Katrak, S;
Pauranik, A;
Desai, S;
Mead, S;
Beck, J;
Brandner, S;
Collinge, J;
(2019)
Familial Creutzfeldt-Jakob disease in an Indian kindred.
Annals of Indian Academy of Neurology
, 22
(4)
pp. 458-461.
10.4103/aian.AIAN_214_19.
|
|
|
Kehoe, PG;
Al Mulhim, N;
Zetterberg, H;
Blennow, K;
Miners, JS;
(2019)
Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
Journal of Alzheimer’s Disease
, 72
(2)
pp. 525-535.
10.3233/JAD-190721.
|
|
|
Keshavan, Ashvini;
(2019)
Blood and cerebrospinal fluid biomarkers for Alzheimer’s disease: from clinical to preclinical cohorts.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Keuss, SE;
Bowen, J;
Schott, JM;
(2019)
Looking beyond the eyes: visual impairment in posterior cortical atrophy.
[Editorial comment].
The Lancet
, 394
(10203)
p. 1055.
10.1016/S0140-6736(19)31818-5.
|
|
Keuss, SE;
Parker, TD;
Lane, CA;
Hoskote, C;
Shah, S;
Cash, DM;
Keshavan, A;
... Schott, JM; + view all
(2019)
Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort.
BMJ Open
, 9
(7)
, Article e029502. 10.1136/bmjopen-2019-029502.
|
|
|
Khoonsari, PE;
Shevchenko, G;
Herman, S;
Remnestål, J;
Giedraitis, V;
Brundin, R;
Gunnarsson, MD;
... Kultima, K; + view all
(2019)
Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
Journal of Alzheimer's Disease
, 67
(2)
pp. 639-651.
10.3233/JAD-180855.
|
|
|
Kim, J;
Lana, B;
Torelli, S;
Ryan, D;
Catapano, F;
Ala, P;
Luft, C;
... Lin, Y-Y; + view all
(2019)
A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan.
EMBO Reports
, Article e47967. 10.15252/embr.201947967.
(In press).
|
|
|
Kim, M;
Snowden, S;
Suvitaival, T;
Ali, A;
Merkler, DJ;
Ahmad, T;
Westwood, S;
... Legido-Quigley, C; + view all
(2019)
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimer's & Dementia
, 15
(6)
pp. 817-827.
10.1016/j.jalz.2019.03.004.
|
|
Koriath, C;
Lashley, T;
Taylor, W;
Druyeh, R;
Dimitriadis, A;
Denning, N;
Williams, J;
... Mead, S; + view all
(2019)
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 277-280.
10.1016/j.dadm.2019.01.010.
|
|
|
Kovac, S;
Preza, E;
Houlden, H;
Walker, MC;
Abramov, AY;
(2019)
Impaired Bioenergetics in Mutant Mitochondrial DNA Determines Cell Fate During Seizure-Like Activity.
Molecular Neurobiology
, 56
(1)
pp. 321-334.
10.1007/s12035-018-1078-9.
|
|
Kranaster, L;
Blennow, K;
Zetterberg, H;
Sartorius, A;
(2019)
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study.
Journal of Affective Disorders
, 253
pp. 449-453.
10.1016/j.jad.2019.04.080.
|
|
Kun-Rodrigues, C;
Orme, T;
Carmona, S;
Hernandez, DG;
Ross, OA;
Eicher, JD;
Shepherd, C;
... Bras, J; + view all
(2019)
A comprehensive screening of copy number variability in dementia with Lewy bodies.
Neurobiology of Aging
, 75
, Article 223.e1-223.e10. 10.1016/j.neurobiolaging.2018.10.019.
|
|
Kundu, S;
Lukemire, J;
Wang, Y;
Guo, Y;
Alzheimer’s Disease Neuroimaging Initiative;
(2019)
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer's Disease Data.
Scientific Reports
, 9
, Article 19589. 10.1038/s41598-019-55818-z.
|
|
|
Kunkle, BW;
Grenier-Boley, B;
Sims, R;
Bis, JC;
Damotte, V;
Naj, AC;
Boland, A;
... Pericak-Vance, MA; + view all
(2019)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature Genetics
, 51
pp. 414-430.
10.1038/s41588-019-0358-2.
|
L
|
Laferrière, F;
Maniecka, Z;
Pérez-Berlanga, M;
Hruska-Plochan, M;
Gilhespy, L;
Hock, E-M;
Wagner, U;
... Polymenidou, M; + view all
(2019)
TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
Nature Neuroscience
, 22
(1)
pp. 65-77.
10.1038/s41593-018-0294-y.
|
|
Lamb, R;
Rohrer, JD;
Real, R;
Lubbe, SJ;
Waite, AJ;
Blake, DJ;
Walters, RJ;
... Morris, HR; + view all
(2019)
A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders.
Cold Spring Harbor Molecular Case Studies
, 5
(3)
, Article a003913. 10.1101/mcs.a003913.
|
|
|
Lane, CA;
Barnes, J;
Nicholas, JM;
Sudre, CH;
Cash, DM;
Malone, IB;
Parker, TD;
... Schott, JM; + view all
(2019)
Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.
JAMA Neurology
, 77
(2)
pp. 175-183.
10.1001/jamaneurol.2019.3774.
|
|
|
Lane, CA;
Barnes, J;
Nicholas, JM;
Sudre, CH;
Cash, DM;
Parker, TD;
Malone, IB;
... Schott, JM; + view all
(2019)
Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.
Lancet Neurology
10.1016/S1474-4422(19)30228-5.
(In press).
|
|
|
Langbehn, DR;
Stout, JC;
Gregory, S;
Mills, JA;
Durr, A;
Leavitt, BR;
Roos, RAC;
... TRACK-HD and Track-On HD Groups; + view all
(2019)
Association of CAG Repeats With Long-term Progression in Huntington Disease.
JAMA Neurology
10.1001/jamaneurol.2019.2368.
(In press).
|
|
Law, LL;
Sprecher, KE;
Dougherty, RJ;
Edwards, DF;
Koscik, RL;
Gallagher, CL;
Carlsson, CM;
... Okonkwo, OC; + view all
(2019)
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort.
Journal of Alzheimer's Disease
, 69
(1)
pp. 111-121.
10.3233/JAD-180291.
|
|
|
Leal, IC;
Rodrigues, FB;
Sousa, DC;
Duarte, G;
Romão, VC;
Marques-Neves, C;
Costa, J;
(2019)
Anti-TNF Drugs for Chronic Uveitis in Adults—A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Frontiers in Medicine
, 6
, Article 104. 10.3389/fmed.2019.00104.
|
|
Leavey, N;
Hammond, SP;
Shepstone, L;
Cross, J;
Zetterberg, H;
Cunningham, C;
MacLullich, A;
... Fox, C; + view all
(2019)
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients.
BMC Neurology
, 19
(1)
, Article 223. 10.1186/s12883-019-1447-7.
|
|
|
Lee, G;
Nho, K;
Kang, B;
Sohn, K-A;
Kim, D;
for Alzheimer’s Disease Neuroimaging Initiative;
(2019)
Predicting Alzheimer's disease progression using multi-modal deep learning approach.
Scientific Reports
, 9
, Article 1952. 10.1038/s41598-018-37769-z.
|
|
|
Leonenko, G;
Shoai, M;
Bellou, E;
Sims, R;
Williams, J;
Hardy, J;
Escott-Price, V;
(2019)
Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
Annals of Neurology
, 86
(3)
pp. 427-435.
10.1002/ana.25530.
|
|
|
Leonenko, G;
Sims, R;
Shoai, M;
Frizzati, A;
Bossu, P;
Spalletta, G;
Fox, NC;
... Munger, R; + view all
(2019)
Polygenic risk and hazard scores for Alzheimer's disease prediction.
Annals of Clinical and Translational Neurology
, 6
(3)
pp. 456-465.
10.1002/acn3.716.
|
|
|
Lerche, S;
Wurster, I;
Röben, B;
Machetanz, G;
Zimmermann, M;
Bernhard, F;
Stransky, E;
... Brockmann, K; + view all
(2019)
Parkinson’s disease: evolution of cognitive impairment and CSF Aβ₁−₄₂ profiles in a prospective longitudinal study.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(2)
pp. 165-170.
10.1136/jnnp-2018-318956.
|
|
|
Leuzy, A;
Cicognola, C;
Chiotis, K;
Saint-Aubert, L;
Lemoine, L;
Andreasen, N;
Zetterberg, H;
... Nordberg, A; + view all
(2019)
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-018-4242-6.
(In press).
|
|
|
Lewis, MA;
Ganeshan, B;
Barnes, A;
Bisdas, S;
Jaunmuktane, Z;
Brandner, S;
Endozo, R;
... Thust, SC; + view all
(2019)
Filtration-histogram based magnetic resonance texture analysis (MRTA) for glioma IDH and 1p19q genotyping.
European Journal of Radiology
, 113
pp. 116-123.
10.1016/j.ejrad.2019.02.014.
|
|
Leyland, L-A;
Bremner, FD;
Mahmood, R;
Hewitt, S;
Durteste, M;
Cartlidge, MRE;
Lai, MM-M;
... Weil, RS; + view all
(2019)
Visual tests predict dementia risk in Parkinson's disease.
Neurology: Clinical Practice
10.1212/CPJ.0000000000000719.
(In press).
|
|
|
Leyland, L-A;
Spencer, B;
Beale, N;
Jones, T;
van Reekum, CM;
(2019)
The effect of cycling on cognitive function and well-being in older adults.
PLOS ONE
, 14
(2)
, Article e0211779. 10.1371/journal.pone.0211779.
|
|
|
Lleó, A;
Alcolea, D;
Martínez-Lage, P;
Scheltens, P;
Parnetti, L;
Poirier, J;
Simonsen, AH;
... Blennow, K; + view all
(2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
Alzheimer's & Dementia
, 15
(6)
pp. 742-753.
10.1016/j.jalz.2019.01.015.
|
|
Llibre-Guerra, JJ;
Li, Y;
Schindler, SE;
Gordon, BA;
Fagan, AM;
Morris, JC;
Benzinger, TLS;
... McDade, E; + view all
(2019)
Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease.
JAMA Network Open
, 2
(12)
, Article e1917126. 10.1001/jamanetworkopen.2019.17126.
|
|
|
Lombardi, V;
Bombaci, A;
Zampedri, L;
Lu, C-H;
Malik, B;
Zetterberg, H;
Heslegrave, AJ;
... Fratta, P; + view all
(2019)
Plasma pNfH levels differentiate SBMA from ALS.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320624.
(In press).
|
|
|
Lombardi, V;
Querin, G;
Ziff, OJ;
Zampedri, L;
Martinelli, I;
Heller, C;
Foiani, M;
... Fratta, P; + view all
(2019)
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
Neurology
, 92
(11)
10.1212/WNL.0000000000007097.
(In press).
|
|
|
Lopez-Font, I;
Boix, CP;
Zetterberg, H;
Blennow, K;
Sáez-Valero, J;
(2019)
Characterization of Cerebrospinal Fluid BACE1 Species.
Molecular Neurobiology
, 56
pp. 8603-8616.
10.1007/s12035-019-01677-8.
|
|
Lopez-Font, I;
Sogorb-Esteve, A;
Javier-Torrent, M;
Brinkmalm, G;
Herrando-Grabulosa, M;
García-Lareu, B;
Turon-Sans, J;
... Sáez-Valero, J; + view all
(2019)
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Neurobiology of Disease
, 124
pp. 428-438.
10.1016/j.nbd.2018.12.021.
|
|
Lowe, AJ;
Paquola, C;
Vos de Wael, R;
Girn, M;
Lariviere, S;
Tavakol, S;
Caldairou, B;
... Bernhardt, BC; + view all
(2019)
Targeting age‐related differences in brain and cognition with multimodal imaging and connectome topography profiling.
Human Brain Mapping
, 40
(18)
pp. 5213-5230.
10.1002/hbm.24767.
|
|
|
Lu, K;
Nicholas, JM;
Collins, JD;
James, S-N;
Parker, TD;
Lane, CA;
Keshavan, A;
... Schott, JM; + view all
(2019)
Cognition at age 70: Life course predictors and associations with brain pathologies.
Neurology
, 93
10.1212/WNL.0000000000008534.
|
|
|
Lu, Kirsty;
(2019)
Characterising cognition in later life and its relationship with biomarkers of Alzheimer's disease: a study of members of the National Survey of Health and Development (the British 1946 birth cohort).
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Lu, M;
Banetta, L;
Young, LJ;
Smith, EJ;
Bates, GP;
Zaccone, A;
Schierle, GSK;
... Kaminski, CF; + view all
(2019)
Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly.
Journal of Biological Chemistry
, 294
(1)
pp. 257-268.
10.1074/jbc.RA118.003500.
|
|
|
Lynch, DS;
Wade, C;
Paiva, ARBD;
John, N;
Kinsella, JA;
Merwick, Á;
Ahmed, RM;
... Chataway, J; + view all
(2019)
Practical approach to the diagnosis of adult-onset leukodystrophies: an updated guide in the genomic era.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(5)
pp. 543-554.
10.1136/jnnp-2018-319481.
|
M
|
Ma, Y;
Jun, GR;
Chung, J;
Zhang, X;
Kunkle, BW;
Naj, AC;
White, CC;
... Yu, L; + view all
(2019)
CpG-related SNPs in the MS4A region have a dose-dependent effect on risk of late-onset Alzheimer disease.
Aging Cell
, 18
(4)
, Article e12964. 10.1111/acel.12964.
|
|
|
MacGregor Sharp, M;
Bulters, D;
Brandner, S;
Holton, J;
Verma, A;
Werring, DJ;
Carare, RO;
(2019)
The fine anatomy of the perivascular compartment in the human brain: relevance to dilated perivascular spaces in cerebral amyloid angiopathy.
Neuropathology and Applied Neurobiology
, 45
(3)
pp. 305-308.
10.1111/nan.12480.
|
|
Mackintosh, M;
Gonzalez-Izquierdo, A;
Rossor, M;
Whitaker, K;
Direk, K;
Denaxas, S;
(2019)
Network Structures and Dynamics Of Early Dementia Events Recorded in Primary Care Electronic Health Records.
In: Kostkova, P and Wood, C and Bosman, A and Grasso, F and Edelstein, M, (eds.)
DPH2019: Proceedings of the International Conference on Digital Public Health.
(pp. p. 127).
Association for Computing Machinery (ACM): New York, NY, USA.
|
|
|
Magno, L;
Lessard, CB;
Martins, M;
Lang, V;
Cruz, P;
Asi, Y;
Katan, M;
... Whiting, PJ; + view all
(2019)
Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph.
Alzheimer's Research & Therapy
, 11
, Article 16. 10.1186/s13195-019-0469-0.
|
|
|
Malek, N;
Kanavou, S;
Lawton, MA;
Pitz, V;
Grosset, KA;
Bajaj, N;
Barker, RA;
... PRoBaND clinical consortium; + view all
(2019)
L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression.
Parkinsonism & Related Disorders
, 65
pp. 55-61.
10.1016/j.parkreldis.2019.05.022.
|
|
Marinescu, RV;
Eshaghi, A;
Lorenzi, M;
Young, AL;
Oxtoby, NP;
Garbarino, S;
Crutch, SJ;
... Alzheimer's Disease Neuroimaging Initiative, .; + view all
(2019)
DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders.
NeuroImage
, 192
pp. 166-177.
10.1016/j.neuroimage.2019.02.053.
|
|
|
Marinescu, RV;
Lorenzi, M;
Blumberg, SB;
Young, AL;
Planell-Morell, P;
Oxtoby, NP;
Eshaghi, A;
... Alexander, DC; + view all
(2019)
Disease Knowledge Transfer Across Neurodegenerative Diseases.
In:
Medical Image Computing and Computer Assisted Intervention – MICCAI 2019.
(pp. pp. 860-868).
Springer Nature: Cham, Switzerland.
|
|
Marinescu, RV;
Oxtoby, NP;
Young, AL;
Bron, EE;
Toga, AW;
Weiner, MW;
Barkhof, F;
... Alexander, DC; + view all
(2019)
TADPOLE Challenge: Accurate Alzheimer’s Disease Prediction Through Crowdsourced Forecasting of Future Data.
In: Rekik, I and Adeli, E and Park, SH, (eds.)
Predictive Intelligence in Medicine.
(pp. pp. 1-10).
Springer,: Cham, Switzerland.
|
|
Marini, S;
Crawford, K;
Morotti, A;
Lee, MJ;
Pezzini, A;
Moomaw, CJ;
Flaherty, ML;
... Sheth, K; + view all
(2019)
Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity: A Meta-analysis.
JAMA Neurology
, 76
(4)
pp. 480-491.
10.1001/jamaneurol.2018.4519.
|
|
Marshall, CR;
Hardy, CJD;
Russell, LL;
Bond, RL;
Sivasathiaseelan, H;
Greaves, C;
Moore, KM;
... Warren, JD; + view all
(2019)
The functional neuroanatomy of emotion processing in frontotemporal dementias.
Brain
, 142
(9)
pp. 2873-2887.
10.1093/brain/awz204.
|
|
Mauricio, R;
Benn, C;
Davis, J;
Dawson, G;
Dawson, LA;
Evans, A;
Fox, N;
... Whiting, P; + view all
(2019)
Tackling gaps in developing life-changing treatments for dementia.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 5
pp. 241-253.
10.1016/j.trci.2019.05.001.
|
|
|
McAleenan, A;
Howell, A;
Kernohan, A;
Faulkner, CL;
Dawson, S;
Wragg, C;
Jefferies, S;
... Kurian, KM; + view all
(2019)
Prognostic value of test(s) for O⁶ - methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide.
Cochrane Database of Systematic Reviews
(4)
, Article CD013316. 10.1002/14651858.CD013316.
|
|
McAleenan, A;
Jones, HE;
Kernohan, A;
Faulkner, CL;
Palmer, A;
Dawson, S;
Wragg, C;
... Kurian, KM; + view all
(2019)
Diagnostic test accuracy and cost‐effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database of Systematic Reviews
, 2019
(8)
, Article CD013387. 10.1002/14651858.CD013387.
|
|
McCarthy, I;
Suzuki, T;
Holloway, C;
Poole, T;
Frost, C;
Carton, A;
Tyler, N;
... Yong, K; + view all
(2019)
Detection and Localisation of Hesitant Steps in People with Alzheimer's Disease Navigating Routes of Varying Complexity.
Healthcare Technology Letters
, 6
(2)
pp. 42-47.
10.1049/htl.2018.5034.
|
|
|
McIntyre, A;
Harding, E;
Yong, KXX;
Sullivan, MP;
Gilhooly, M;
Gilhooly, K;
Woodbridge, R;
(2019)
Health and social care practitioners' understanding of the problems of people with dementia‐related visual processing impairment.
Health & Social Care in the Community
, 27
(4)
pp. 982-990.
10.1111/hsc.12715.
|
|
Medawar, E;
Benway, TA;
Liu, W;
Hanan, TA;
Haslehurst, P;
James, OT;
Yap, K;
... Edwards, FA; + view all
(2019)
Effects of rising amyloidβ levels on hippocampal synaptic transmission, microglial response and cognition in APP_{Swe}/PSEN1_{M146V} transgenic mice.
EBioMedicine
, 39
pp. 422-435.
10.1016/j.ebiom.2018.12.006.
|
|
Meeter, LHH;
Steketee, RME;
Salkovic, D;
Vos, ME;
Grossman, M;
McMillan, CT;
Irwin, DJ;
... Van Swieten, JC; + view all
(2019)
Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2018-319784.
(In press).
|
|
|
Merluzzi, AP;
Vogt, NM;
Norton, D;
Jonaitis, E;
Clark, LR;
Carlsson, CM;
Johnson, SC;
... Bendlin, BB; + view all
(2019)
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 5
pp. 129-138.
10.1016/j.trci.2019.02.004.
|
|
|
Metzer, WS;
Brogueira Rodrigues, F;
(2019)
Managing treatment fluctuations in Parkinson disease: “On” again–, “off” again.
Neurology
10.1212/WNL.0000000000007193.
(In press).
|
|
Michno, W;
Nyström, S;
Wehrli, P;
Lashley, T;
Brinkmalm, G;
Guerard, L;
Syvänen, S;
... Hanrieder, J; + view all
(2019)
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Journal of Biological Chemistry
, 294
pp. 6719-6732.
10.1074/jbc.RA118.006604.
|
|
Michno, W;
Wehrli, PM;
Blennow, K;
Zetterberg, H;
Hanrieder, J;
(2019)
Molecular imaging mass spectrometry for probing protein dynamics in neurodegenerative disease pathology.
Journal of Neurochemistry
, 151
(4)
pp. 488-506.
10.1111/jnc.14559.
|
|
Michno, W;
Wehrli, PM;
Zetterberg, H;
Blennow, K;
Hanrieder, J;
(2019)
GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
, 1867
(5)
pp. 458-467.
10.1016/j.bbapap.2018.09.010.
|
|
Mielke, MM;
Syrjanen, JA;
Blennow, K;
Zetterberg, H;
Skoog, I;
Vemuri, P;
Machulda, MM;
... Kern, S; + view all
(2019)
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Alzheimer's & Dementia
, 15
(11)
pp. 1437-1447.
10.1016/j.jalz.2019.07.009.
|
|
Mielke, MM;
Syrjanen, JA;
Blennow, K;
Zetterberg, H;
Vemuri, P;
Skoog, I;
Machulda, MM;
... Kern, S; + view all
(2019)
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.
Neurology
, 93
(3)
e252-e260.
10.1212/WNL.0000000000007767.
|
|
Miki, Y;
Foti, SC;
Asi, YT;
Tsushima, E;
Quinn, N;
Ling, H;
Holton, JL;
(2019)
Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
Brain
, 142
(9)
pp. 2813-2827.
10.1093/brain/awz189.
|
|
Miners, JS;
Kehoe, PG;
Love, S;
Zetterberg, H;
Blennow, K;
(2019)
CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
Alzheimer's Research & Therapy
, 11
(1)
, Article 81. 10.1186/s13195-019-0534-8.
|
|
|
Minta, K;
Cullen, NC;
Nimer, FA;
Thelin, EP;
Piehl, F;
Clarin, M;
Tullberg, M;
... Andreasson, U; + view all
(2019)
Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.
Clinical Chemistry and Laboratory Medicine
, 57
(10)
pp. 1565-1573.
10.1515/cclm-2019-0034.
|
|
Minta, K;
Portelius, E;
Janelidze, S;
Hansson, O;
Zetterberg, H;
Blennow, K;
Andreasson, U;
(2019)
Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease.
Journal Of Alzheimers Disease
, 69
(4)
pp. 1213-1220.
10.3233/JAD-190187.
|
|
Moens, TG;
Niccoli, T;
Wilson, KM;
Atilano, ML;
Birsa, N;
Gittings, LM;
Holbling, BV;
... Isaacs, AM; + view all
(2019)
C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.
Acta Neuropathologica
10.1007/s00401-018-1946-4.
(In press).
|
|
|
Mole, JA;
Baker, IW;
Ottley Munoz, JM;
Danby, M;
Warren, JD;
Butler, CR;
(2019)
Avian agnosia: A window into auditory semantics.
Neuropsychologia
, 134
, Article 107219. 10.1016/j.neuropsychologia.2019.107219.
(In press).
|
|
|
Mollenhauer, B;
DuBois, BF;
Drake, D;
Duong, J;
Blennow, K;
El-Agnaf, O;
Shaw, LM;
... Zetterberg, H; + view all
(2019)
Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study.
Journal of Neurochemistry
, 149
(1)
pp. 126-138.
10.1111/jnc.14569.
|
|
|
Moore, KM;
Nicholas, J;
Grossman, M;
McMillan, CT;
Irwin, DJ;
Massimo, L;
Van Deerlin, VM;
... Geschwind, D; + view all
(2019)
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
The Lancet Neurology
10.1016/s1474-4422(19)30394-1.
(In press).
|
|
|
Morgan, AR;
Touchard, S;
Leckey, C;
O'Hagan, C;
Nevado-Holgado, AJ;
Barkhof, F;
Bertram, L;
... Sheridan, H; + view all
(2019)
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimer's and Dementia
10.1016/j.jalz.2019.03.007.
(In press).
|
|
|
Morón-Oset, J;
Supèr, T;
Esser, J;
Isaacs, AM;
Grönke, S;
Partridge, L;
(2019)
Glycine-alanine dipeptide repeats spread rapidly in a repeat length- and age-dependent manner in the fly brain.
Acta Neuropathologica Communications
, 7
, Article 209. 10.1186/s40478-019-0860-x.
|
|
|
Mortimer, T;
Wainwright, EN;
Patel, H;
Siow, BM;
Jaunmuktane, Z;
Brandner, S;
Scaffidi, P;
(2019)
Redistribution of EZH2 promotes malignant phenotypes by rewiring developmental programmes.
EMBO Rep
, Article e48155. 10.15252/embr.201948155.
(In press).
|
|
|
Müller, H-P;
Huppertz, H-J;
Dreyhaupt, J;
Ludolph, AC;
Tabrizi, SJ;
Roos, RAC;
Durr, A;
... Kassubek, J; + view all
(2019)
Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials.
Parkinsonism & Related Disorders
, 63
pp. 179-184.
10.1016/j.parkreldis.2019.02.004.
|
|
Mullin, S;
Beavan, M;
Bestwick, J;
McNeill, A;
Proukakis, C;
Cox, T;
Hughes, D;
... Schapira, AHV; + view all
(2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Movement Disorders
, 34
(9)
pp. 1365-1373.
10.1002/mds.27775.
|
|
|
Mutsaerts, HJMM;
Mirza, SS;
Petr, J;
Thomas, DL;
Cash, DM;
Bocchetta, M;
de Vita, E;
... GENFI consortium, .; + view all
(2019)
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.
Brain. A Journal of Neurology
10.1093/brain/awz039.
(In press).
|
N
|
Nalls, MA;
Blauwendraat, C;
Vallerga, CL;
Heilbron, K;
Bandres-Ciga, S;
Chang, D;
Tan, M;
... Guerreiro, R; + view all
(2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
The Lancet Neurology
, 18
(12)
pp. 1091-1102.
10.1016/S1474-4422(19)30320-5.
|
|
Niccoli, T;
Partridge, L;
Isaacs, A;
(2019)
RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats.
Nature Neuroscience
, 22
pp. 1383-1388.
10.1038/s41593-019-0455-7.
|
|
Nilsson, IAK;
Millischer, V;
Karrenbauer, VD;
Juréus, A;
Salehi, AM;
Norring, C;
von Hausswolff-Juhlin, Y;
... Landén, M; + view all
(2019)
Plasma neurofilament light chain concentration is increased in anorexia nervosa.
Translational Psychiatry
, 9
(1)
, Article 180. 10.1038/s41398-019-0518-2.
|
|
|
Nortley, R;
Korte, N;
Izquierdo, P;
Hirunpattarasilp, C;
Mishra, A;
Jaunmuktane, Z;
Kyrargyri, V;
... Attwell, D; + view all
(2019)
Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes.
Science
, 365
(6450)
, Article 250. 10.1126/science.aav9518.
|
|
|
Noyce, AJ;
Bandres-Ciga, S;
Kim, J;
Heilbron, K;
Kia, D;
Hemani, G;
Xue, A;
... Singleton, AB; + view all
(2019)
The Parkinson's Disease Mendelian Randomization Research Portal.
Movement Disorders
10.1002/mds.27873.
(In press).
|
|
O
|
Olsen, RK;
Carr, VA;
Daugherty, AM;
La Joie, R;
Amaral, RSC;
Amunts, K;
Augustinack, JC;
... Wisse, LEM; + view all
(2019)
Progress update from the hippocampal subfields group.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 439-449.
10.1016/j.dadm.2019.04.001.
|
|
Olsson, B;
Alberg, L;
Cullen, NC;
Michael, E;
Wahlgren, L;
Kroksmark, A-K;
Rostasy, K;
... Tulinius, M; + view all
(2019)
NFL is a marker of treatment response in children with SMA treated with nusinersen.
Journal of Neurology
, 226
(9)
pp. 2129-2136.
10.1007/s00415-019-09389-8.
|
|
Olsson, B;
Portelius, E;
Cullen, NC;
Sandelius, Å;
Zetterberg, H;
Andreasson, U;
Höglund, K;
... Blennow, K; + view all
(2019)
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
JAMA Neurology
, 76
(3)
pp. 318-325.
10.1001/jamaneurol.2018.3746.
|
|
Olsson, M;
Ärlig, J;
Hedner, J;
Blennow, K;
Zetterberg, H;
(2019)
Repeated lumbar punctures within 3 days may affect CSF biomarker levels.
Fluids Barriers CNS
, 16
, Article 37. 10.1186/s12987-019-0157-2.
|
|
|
Olsson, M;
Ärlig, J;
Hedner, J;
Blennow, K;
Zetterberg, H;
(2019)
Sleep deprivation and plasma biomarkers for Alzheimer's disease.
[Letter].
Sleep Medicine
, 57
pp. 92-93.
10.1016/j.sleep.2018.12.029.
|
|
Onatsu, J;
Vanninen, R;
Jäkälä, P;
Mustonen, P;
Pulkki, K;
Korhonen, M;
Hedman, M;
... Taina, M; + view all
(2019)
Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Journal of Stroke and Cerebrovascular Diseases
, 28
(8)
pp. 2242-2249.
10.1016/j.jstrokecerebrovasdis.2019.05.008.
|
|
Osborn, KE;
Alverio, JM;
Dumitrescu, L;
Pechman, KR;
Alzheimer’s Disease Neuroimaging Initiative, .;
Gifford, KA;
Hohman, TJ;
... Jefferson, AL; + view all
(2019)
Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.
Journal of Alzheimer's Disease
10.3233/JAD-190077.
(In press).
|
|
|
Osborn, KE;
Khan, OA;
Kresge, HA;
Bown, CW;
Liu, D;
Moore, EE;
Gifford, KA;
... Jefferson, AL; + view all
(2019)
Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 700-709.
10.1016/j.dadm.2019.08.008.
|
|
|
Osborne-Crowley, K;
Andrews, SC;
Labuschagne, I;
Nair, A;
Scahill, R;
Craufurd, D;
Tabrizi, SJ;
... TRACK-HD Investigators, .; + view all
(2019)
Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.
Journal of the International Neuropsychological Society
, 25
(5)
pp. 453-461.
10.1017/S1355617718001224.
|
P
|
Palmqvist, S;
Insel, PS;
Stomrud, E;
Janelidze, S;
Zetterberg, H;
Brix, B;
Eichenlaub, U;
... Hansson, O; + view all
(2019)
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
EMBO Molecular Medicine
, Article e11170. 10.15252/emmm.201911170.
(In press).
|
|
|
Palmqvist, S;
Insel, PS;
Zetterberg, H;
Blennow, K;
Brix, B;
Stomrud, E;
The Alzheimer's Disease Neuroimaging Initiative, ADNI;
... Hansson, O; + view all
(2019)
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
Alzheimer's & Dementia
, 15
(2)
pp. 194-204.
10.1016/j.jalz.2018.08.014.
|
|
|
Palmqvist, S;
Janelidze, S;
Stomrud, E;
Zetterberg, H;
Karl, J;
Zink, K;
Bittner, T;
... Hansson, O; + view all
(2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.
JAMA Neurology
, 76
(9)
pp. 1060-1069.
10.1001/jamaneurol.2019.1632.
|
|
|
Pan, X;
Cunningham, EL;
Passmore, AP;
McGuinness, B;
McAuley, DF;
Beverland, D;
O'Brien, S;
... Green, BD; + view all
(2019)
Cerebrospinal Fluid Spermidine, Glutamine and Putrescine Predict Postoperative Delirium Following Elective Orthopaedic Surgery.
Scientific Reports
, 9
(1)
, Article 4191. 10.1038/s41598-019-40544-3.
|
|
|
Paonessa, F;
Evans, LD;
Solanki, R;
Larrieu, D;
Wray, S;
Hardy, J;
Jackson, SP;
(2019)
Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia.
Cell Reports
, 26
(3)
pp. 582-593.
10.1016/j.celrep.2018.12.085.
|
|
Papadopoulou, AS;
Gomez-Paredes, C;
Mason, MA;
Taxy, BA;
Howland, D;
Bates, GP;
(2019)
Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay.
Scientific Reports
, 9
, Article 16137. 10.1038/s41598-019-52411-2.
|
|
|
Parker, TD;
Cash, DM;
Lane, CAS;
Lu, K;
Malone, IB;
Nicholas, JM;
James, S-N;
... Schott, JM; + view all
(2019)
Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
PLoS One
, 14
(10)
, Article e0224030. 10.1371/journal.pone.0224030.
|
|
|
Parker, TD;
Slattery, CF;
Yong, KXX;
Nicholas, JM;
Paterson, RW;
Foulkes, AJM;
Malone, IB;
... Schott, JM; + view all
(2019)
Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease.
NeuroImage: Clinical
, Article 101632. 10.1016/j.nicl.2018.101632.
(In press).
|
|
|
Parker, Thomas David;
(2019)
Investigating the relationship between β-amyloid and grey matter macrostructure and microstructure in ageing and dementia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Paterson, RW;
Gabelle, A;
Lucey, BP;
Barthélemy, NR;
Leckey, CA;
Hirtz, C;
Lehmann, S;
... Bateman, RJ; + view all
(2019)
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.
Nature Reviews Neurology
, 15
pp. 419-427.
10.1038/s41582-019-0222-0.
|
|
Pavisic, IM;
Yong, KXX;
Primativo, S;
Crutch, SJ;
Suarez Gonzalez, A;
(2019)
Unusual Pattern of Reading Errors in a Patient with Posterior Cortical Atrophy.
Case Reports in Neurology
, 11
pp. 157-166.
10.1159/000500081.
|
|
|
Pedersen, A;
Stanne, TM;
Nilsson, S;
Klasson, S;
Rosengren, L;
Holmegaard, L;
Jood, K;
... Jern, C; + view all
(2019)
Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.
Journal of Neurology
10.1007/s00415-019-09477-9.
(In press).
|
|
|
Perez-Rodriguez, D;
Kalyva, M;
Leija-Salazar, M;
Lashley, T;
Tarabichi, M;
Chelban, V;
Gentleman, S;
... Proukakis, C; + view all
(2019)
Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.
Acta Neuropathologica Communications
, 7
(1)
, Article 219. 10.1186/s40478-019-0873-5.
|
|
|
Petit, D;
Hitzenberger, M;
Lismont, S;
Zoltowska, KM;
Ryan, NS;
Mercken, M;
Bischoff, F;
... Chávez-Gutiérrez, L; + view all
(2019)
Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ-secretase modulators.
The EMBO Journal
, Article e101494. 10.15252/embj.2019101494.
(In press).
|
|
Pido-Lopez, J;
Tanudjojo, B;
Farag, S;
Bondulich, M-K;
Andre, R;
Tabrizi, SJ;
Bates, GP;
(2019)
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment.
Scientific Reportsvolume
, 9
(1)
, Article 7202. 10.1038/s41598-019-43627-3.
|
|
Piers, TM;
Cosker, K;
Mallach, A;
Johnson, GT;
Guerreiro, R;
Hardy, J;
Pocock, JM;
(2019)
A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia.
FASEB Journal
10.1096/fj.201902447R.
|
|
|
Pillai, A;
Bruno, D;
Nierenberg, J;
Pandya, C;
Feng, T;
Reichert, C;
Ramos-Cejudo, J;
... Pomara, N; + view all
(2019)
Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder.
Biomarkers in Neuropsychiatry
, 1
, Article 100007. 10.1016/j.bionps.2019.100007.
|
|
|
Pope, S;
Artuch, R;
Heales, S;
Rahman, S;
(2019)
Cerebral folate deficiency: Analytical tests and differential diagnosis.
Journal of Inherited Metabolic Disease
, 42
(4)
pp. 655-672.
10.1002/jimd.12092.
|
|
Posti, JP;
Takala, RS;
Lagerstedt, L;
Dickens, AM;
Hossain, I;
Mohammadian, M;
Ala-Seppälä, HM;
... Blennow, K; + view all
(2019)
Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.
Journal of Neurotrauma
, 36
(14)
pp. 2178-2189.
10.1089/neu.2018.6254.
|
|
Pottier, C;
Ren, Y;
Perkerson, RB;
Baker, M;
Jenkins, GD;
Van Blitterswijk, M;
DeJesus-Hernandez, M;
... Rademakers, R; + view all
(2019)
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
Acta Neuropathologica
, 137
(6)
pp. 879-899.
10.1007/s00401-019-01962-9.
|
|
|
Preische, O;
Schultz, SA;
Apel, A;
Kuhle, J;
Kaeser, SA;
Barro, C;
Gräber, S;
... Dominantly Inherited Alzheimer Network; + view all
(2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
Nature Medicine
, 25
(2)
pp. 277-283.
10.1038/s41591-018-0304-3.
|
|
Premi, E;
Calhoun, VD;
Diano, M;
Gazzina, S;
Cosseddu, M;
Alberici, A;
Archetti, S;
... Genetic FTD Initiative, GENFI; + view all
(2019)
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.
NeuroImage
, 189
pp. 645-654.
10.1016/j.neuroimage.2019.01.080.
|
|
|
Psarras, S;
Fatah gen. Schieck, A;
Zarkali, A;
Hanna, S;
(2019)
Visual Saliency in Navigation: Modelling Navigational Behaviour using Saliency and Depth Analysis.
In:
Proceedings of the 12th International Space Syntax Symposium.
International Space Syntax Symposium: Beijing, China.
|
|
|
Pujol-Calderón, F;
Portelius, E;
Zetterberg, H;
Blennow, K;
Rosengren, LE;
Höglund, K;
(2019)
Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
Neuroscience Letters
, 698
pp. 58-63.
10.1016/j.neulet.2018.12.042.
|
Q
|
Quarrell, OWJ;
Nance, MA;
Nopoulos, P;
Reilmann, R;
Oosterloo, M;
Tabrizi, SJ;
Furby, H;
... Juvenile Huntington Disease Working Group of the European Huntin, .; + view all
(2019)
Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease?
[Letter].
Movement Disorders
10.1002/mds.27640.
(In press).
|
R
|
Racine, AM;
Merluzzi, AP;
Adluru, N;
Norton, D;
Koscik, RL;
Clark, LR;
Berman, SE;
... Johnson, SC; + view all
(2019)
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.
Brain Imaging and Behavior
, 13
(1)
pp. 41-52.
10.1007/s11682-017-9732-9.
|
|
|
Raffaele, F;
Claudia, M;
John, H;
(2019)
Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues.
Neurobiology of Aging
, 78
pp. 98-110.
10.1016/j.neurobiolaging.2019.02.006.
|
|
Rajan, MR;
Sotak, M;
Barrenas, F;
Shen, T;
Borkowski, K;
Ashton, NJ;
Biorserud, C;
... Borgeson, E; + view all
(2019)
Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum.
Scientific Reports
, 9
, Article 15385. 10.1038/s41598-019-51673-0.
|
|
|
Raposo, M;
Ramos, A;
Santos, C;
Kazachkova, N;
Teixeira, B;
Bettencourt, C;
Lima, M;
(2019)
Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease.
Molecular Neurobiology
, 56
(1)
pp. 119-124.
10.1007/s12035-018-1069-x.
|
|
Rees, J;
Weil, R;
Solomons, M;
Jaumuktane, Z;
Brandner, S;
El-Hassan, T;
(2019)
Survival and seizure control have improved for adult low-grade gliomas over the last eleven years.
Presented at: The British Neuro-Oncology Society Annual Meeting, London, UK.
|
|
Reindl, W;
Baldo, B;
Schulz, J;
Janack, I;
Lindner, I;
Kleinschmidt, M;
Sedaghat, Y;
... Macdonald, D; + view all
(2019)
Meso scale discovery-based assays for the detection of aggregated huntingtin.
PLOS ONE
, 14
(3)
, Article e0213521. 10.1371/journal.pone.0213521.
|
|
|
Reinhardt, A;
Stichel, D;
Schrimpf, D;
Koelsche, C;
Wefers, AK;
Ebrahimi, A;
Sievers, P;
... von Deimling, A; + view all
(2019)
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities.
Acta Neuropathologica Communications
, 7
(1)
, Article 163. 10.1186/s40478-019-0801-8.
|
|
|
Reynolds, RH;
Botía, J;
Nalls, MA;
International Parkinson’s Disease Genomics Consortium (IPDGC), .;
System Genomics of Parkinson’s Disease (SGPD), .;
Hardy, J;
Gagliano Taliun, SA;
(2019)
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability.
NPJ Parkinson's Disease
, 5
, Article 6. 10.1038/s41531-019-0076-6.
|
|
|
Reynolds, RH;
Hardy, J;
Ryten, M;
Gagliano Taliun, SA;
(2019)
Informing disease modelling with brain-relevant functional genomic annotations.
Brain
10.1093/brain/awz295.
(In press).
|
|
|
Ribbe, M;
Kern, S;
Börjesson Hansson, A;
Östling, S;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2019)
Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death.
Dementia and Geriatric Cognitive Disorders
, 47
(1-2)
pp. 114-123.
10.1159/000499066.
|
|
Rittman, T;
Borchert, R;
Jones, S;
van Swieten, J;
Borroni, B;
Galimberti, D;
Masellis, M;
... Genetic Frontotemporal Dementia Initiative (GENFI); + view all
(2019)
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.
Neurobiology of Aging
, 77
pp. 169-177.
10.1016/j.neurobiolaging.2018.12.009.
|
|
|
Rizzo, G;
De Blasi, R;
Capozzo, R;
Tortelli, R;
Barulli, MR;
Liguori, R;
Grasso, D;
(2019)
Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies.
Journal of Alzheimer's Disease
, 67
(1)
pp. 61-65.
10.3233/JAD-180687.
|
|
|
Rodrigues, FB;
Duarte, GS;
Prescott, D;
Ferreira, J;
Costa, J;
(2019)
Deep brain stimulation for dystonia.
Cochrane Database of Systematic Reviews
, 1
, Article CD012405. 10.1002/14651858.CD012405.pub2.
|
|
Rodrigues, FB;
Ferreira, JJ;
(2019)
The risks of converting post-hoc findings into primary outcomes in subsequent trials.
Annals of Translational Medicine
, 7
(8)
, Article S337. 10.21037/atm.2019.09.105.
|
|
|
Rosén, A;
Oscarsson, N;
Kvarnström, A;
Gennser, M;
Sandström, G;
Blennow, K;
Seeman-Lodding, H;
(2019)
Serum tau concentration after diving - an observational pilot study.
Diving and Hyperbaric Medicine
, 49
(2)
pp. 88-95.
10.28920/dhm49.2.88-95.
|
|
Ross, CA;
Reilmann, R;
Cardoso, F;
McCusker, EA;
Testa, CM;
Stout, JC;
Leavitt, BR;
... Tabrizi, SJ; + view all
(2019)
Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.
Movement Disorders Clinical Practice
, 6
(7)
pp. 541-546.
10.1002/mdc3.12808.
|
|
|
Rossor, AM;
Jaunmuktane, Z;
Rossor, MN;
Hoti, G;
Reilly, MM;
(2019)
TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN.
Neurology
, 92
e951-e956.
10.1212/WNL.0000000000007008.
|
|
|
Rubin, LH;
Tierney, R;
Kawata, K;
Wesley, L;
Lee, JH;
Blennow, K;
Zetterberg, H;
(2019)
NFL blood levels are moderated by subconcussive impacts in a cohort of college football players.
Brain Injury
, 33
(4)
pp. 456-462.
10.1080/02699052.2019.1565895.
|
|
Rudge, P;
Jaunmuktane, Z;
Hyare, H;
Ellis, M;
Koltzenburg, M;
Collinge, J;
Brandner, S;
(2019)
Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease.
Brain
10.1093/brain/awy358.
(In press).
|
|
|
Rydén, L;
Zettergren, A;
Seidu, NM;
Guo, X;
Kern, S;
Blennow, K;
Zetterberg, H;
... Skoog, I; + view all
(2019)
Atrial fibrillation increases the risk of dementia among older adults even in the absence of stroke.
Journal of Internal Medicine
, 286
(1)
pp. 101-110.
10.1111/joim.12902.
|
S
|
Salih, DA;
Bayram, S;
Guelfi, S;
Reynolds, RH;
Shoai, M;
Ryten, M;
Brenton, J;
... Hardy, J; + view all
(2019)
Genetic variability in response to amyloid beta deposition influences Alzheimer's disease risk.
Brain Communications
10.1093/braincomms/fcz022.
(In press).
|
 |
|
Saller, T;
Petzold, A;
Zetterberg, H;
Kuhle, J;
Chappell, D;
von Dossow, V;
Klawitter, F;
... Ehler, J; + view all
(2019)
A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Rep.
, 163
(3)
pp. 241-246.
10.5507/bp.2019.043.
|
|
|
Salpietro, V;
Dixon, CL;
Guo, H;
Bello, OD;
Vandrovcova, J;
Efthymiou, S;
Maroofian, R;
... Houlden, H; + view all
(2019)
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.
Nature Communications
, 10
(1)
, Article 3094. 10.1038/s41467-019-10910-w.
|
|
|
Salvadó, G;
Molinuevo, JL;
Brugulat-Serrat, A;
Falcon, C;
Grau-Rivera, O;
Suárez-Calvet, M;
Pavia, J;
... Alzheimer’s Disease Neuroimaging Initiative, for the ALFA Study, .; + view all
(2019)
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers.
Alzheimer's Research and Therapy
, 11
, Article 27. 10.1186/s13195-019-0478-z.
|
|
|
Sandelius, A;
Portelius, E;
Kallen, A;
Zetterberg, H;
Rot, U;
Olsson, B;
Toledo, JB;
... Blennow, K; + view all
(2019)
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
Alzheimer's & Dementia
, 15
(1)
pp. 55-64.
10.1016/j.jalz.2018.08.006.
|
|
|
Sandelius, Å;
Sandgren, S;
Axelsson, M;
Malmeström, C;
Novakova, L;
Kostanjevecki, V;
Vandijck, M;
... Lycke, J; + view all
(2019)
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Scientific Reports
, 9
, Article 17309. 10.1038/s41598-019-54032-1.
|
|
|
Sanfilippo, C;
Castrogiovanni, P;
Imbesi, R;
Kazakowa, M;
Musumeci, G;
Blennow, K;
Zetterberg, H;
(2019)
Sex Difference in CHI3L1 Expression Levels in Human Brain Aging and in Alzheimer's Disease.
Brain Research
, 1720
, Article 146305. 10.1016/j.brainres.2019.146305.
|
|
Sani, TP;
Bond, RL;
Marshall, CR;
Hardy, CJD;
Russell, LL;
Moore, KM;
Slattery, CF;
... Warren, JD; + view all
(2019)
Sleep symptoms in syndromes of frontotemporal dementia and Alzheimer's disease: A proof-of-principle behavioural study.
eNeurologicalSci
, 17
, Article 100212. 10.1016/j.ensci.2019.100212.
|
|
|
Santillo, AF;
Lundgren, S;
Xu, C;
Orhan, F;
Fatouros-Bergman, H;
Blennow, K;
Zetterberg, H;
... Engberg, G; + view all
(2019)
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.
Schizophrenia Research
, 208
pp. 490-492.
10.1016/j.schres.2019.01.010.
|
|
Schiza, N;
Georgiou, E;
Kagiava, A;
Médard, J-J;
Richter, J;
Tryfonos, C;
Sargiannidou, I;
... Kleopa, KA; + view all
(2019)
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
Brain
, Article awz064. 10.1093/brain/awz064.
(In press).
|
|
|
Schott, JM;
Crutch, SJ;
(2019)
Posterior Cortical Atrophy.
CONTINUUM: Lifelong Learning in Neurology
, 25
(1)
pp. 52-75.
10.1212/CON.0000000000000696.
|
|
Shafei, R;
Woollacott, IOC;
Mummery, CJ;
Bocchetta, M;
Guerreiro, R;
Bras, J;
Warren, JD;
... Rohrer, JD; + view all
(2019)
Two pathologically confirmed cases of novel mutations in the MAPT gene causing frontotemporal dementia.
Neurobiology of Aging
10.1016/j.neurobiolaging.2019.11.009.
(In press).
|
|
|
Shi, L;
Westwood, S;
Baird, AL;
Winchester, L;
Dobricic, V;
Kilpert, F;
Hong, S;
... Nevado-Holgado, AJ; + view all
(2019)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimer's and Dementia
10.1016/j.jalz.2019.06.4951.
(In press).
|
|
|
Shibata-Germanos, S;
Goodman, JR;
Grieg, A;
Trivedi, CA;
Benson, BC;
Foti, SC;
Faro, A;
... Rihel, J; + view all
(2019)
Structural and functional conservation of non-lumenized lymphatic endothelial cells in the mammalian leptomeninges.
Acta Neuropathologica
10.1007/s00401-019-02091-z.
(In press).
|
|
|
Shribman, S;
Alexander, SK;
Zarkali, A;
Warner, TT;
Pereira, AC;
Hughes, TAT;
Mummery, CJ;
(2019)
Training in neurology: lessons learnt.
Practical Neurology
, 19
(5)
pp. 431-437.
10.1136/practneurol-2018-002129.
|
|
|
Sievers, P;
Appay, R;
Schrimpf, D;
Stichel, D;
Reuss, DE;
Wefers, AK;
Reinhardt, A;
... Jones, DTW; + view all
(2019)
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
Acta Neuropathologica
, 138
pp. 497-504.
10.1007/s00401-019-02038-4.
|
|
Simrén, J;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2019)
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead.
Current Opinion in Neurobiology
, 61
pp. 29-39.
10.1016/j.conb.2019.11.019.
|
|
Singleton, A;
Hardy, J;
(2019)
Progress in the genetic analysis of Parkinson’s disease.
Human Molecular Genetics
, 28
(R2)
R215-R218.
10.1093/hmg/ddz183.
|
|
Sivasathiaseelan, H;
Marshall, CR;
Agustus, JL;
Benhamou, E;
Bond, RL;
van Leeuwen, JEP;
Hardy, CJD;
... Warren, JD; + view all
(2019)
Frontotemporal Dementia: A Clinical Review.
Seminars in Neurology
, 39
(2)
pp. 251-263.
10.1055/s-0039-1683379.
|
|
Sjödin, S;
Brinkmalm, G;
Öhrfelt, A;
Parnetti, L;
Paciotti, S;
Hansson, O;
Hardy, J;
... Brinkmalm, A; + view all
(2019)
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.
Alzheimer's Research & Therapy
, 11
, Article 82. 10.1186/s13195-019-0533-9.
|
|
Sjögren, M;
Soylu-Kucharz, R;
Dandunna, U;
Stan, TL;
Cavalera, M;
Sandelius, Å;
Zetterberg, H;
(2019)
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.
Neurobiology of Disease
, 132
, Article 104560. 10.1016/j.nbd.2019.104560.
|
|
Sjörsa Dhlman, A;
Blennow, K;
Zetterberg, H;
Glise, K;
Jonsdottir, IH;
(2019)
Growth factors and neurotrophins in patients with stress-related exhaustion disorder.
Psychoneuroendocrinology
, 109
, Article 104415. 10.1016/j.psyneuen.2019.104415.
|
|
Skillback, T;
Kornhuber, J;
Blennow, K;
Zetterberg, H;
Lewczuk, P;
(2019)
Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 69
(2)
pp. 551-559.
10.3233/JAD-190067.
|
|
|
Slattery, CF;
Agustus, JL;
Paterson, RW;
McCallion, O;
Foulkes, AJM;
Macpherson, K;
Carton, AM;
... Warren, JD; + view all
(2019)
The functional neuroanatomy of musical memory in Alzheimer's disease.
Cortex
10.1016/j.cortex.2019.02.003.
(In press).
|
|
|
Smith, R;
Scholl, M;
Leuzy, A;
Jogi, J;
Ohlsson, T;
Strandberg, O;
Hansson, O;
(2019)
Head-to-head comparison of tau positron emission tomography tracers [F-18]flortaucipir and [F-18]RO948.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-019-04496-0.
(In press).
|
|
|
Sng, LMF;
Thomson, PC;
Trabzuni, D;
(2019)
Genome-wide human brain eQTLs: In-depth analysis and insights using the UKBEC dataset.
Scientific Reports
, 9
(1)
, Article 19201. 10.1038/s41598-019-55590-0.
|
|
|
Sonustun, B;
Strand, C;
Foti, S;
Warner, TT;
Lashuel, H;
Holton, JL;
Bandopadhyay, R;
(2019)
Investigation of alpha-synuclein post-translational modifications in idiopathic Parkinson's disease and multiple system atrophy.
In:
(Proceedings) 120th Meeting of the British-Neuropathological-Society (BNS) / Developmental Neuropathology Symposium.
(pp. p. 19).
WILEY
|
|
Soutar, MPM;
Kempthorne, L;
Annuario, E;
Luft, C;
Wray, S;
Ketteler, R;
Ludtmann, MHR;
(2019)
FBS/BSA media concentration determines CCCP's ability to depolarize mitochondria and activate PINK1-PRKN mitophagy.
Autophagy
, 15
(11)
pp. 2002-2011.
10.1080/15548627.2019.1603549.
|
|
Spencer, B;
Jones, T;
Leyland, LA;
van Reekum, CM;
Beale, N;
(2019)
‘Instead of “closing down” at our ages … we’re thinking of exciting and challenging things to do’: older people’s microadventures outdoors on (e-)bikes.
Journal of Adventure Education and Outdoor Learning
, 19
(2)
pp. 124-139.
10.1080/14729679.2018.1558080.
|
|
Staffaroni, AM;
Kramer, AO;
Casey, M;
Kang, H;
Rojas, JC;
Orrú, CD;
Caughey, B;
... Geschwind, MD; + view all
(2019)
Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.
JAMA Neurology
10.1001/jamaneurol.2019.1071.
(In press).
|
|
Stamate, D;
Kim, M;
Proitsi, P;
Westwood, S;
Baird, A;
Nevado-Holgado, A;
Hye, A;
... Legido-Quigley, C; + view all
(2019)
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 5
pp. 933-938.
10.1016/j.trci.2019.11.001.
|
|
|
Startin, CM;
Ashton, NJ;
Hamburg, S;
Hithersay, R;
Wiseman, FK;
Mok, KY;
Hardy, J;
... Strydom, A; + view all
(2019)
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
Alzheimer's Research & Therapy
, 11
, Article 26. 10.1186/s13195-019-0477-0.
|
|
|
Startin, CM;
Hamburg, S;
Strydom, A;
Strydom, A;
Fisher, E;
Nizetic, D;
Hardy, J;
... Karmiloff-Smith, A; + view all
(2019)
Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome.
Frontiers in Psychology
, 9
, Article 2730. 10.3389/fpsyg.2018.02730.
|
|
|
Startin, CM;
Lowe, B;
Hamburg, S;
Hithersay, R;
Strydom, A;
Fisher, E;
Nizetic, D;
... Karmiloff-Smith, A; + view all
(2019)
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.
Frontiers in Psychiatry
, 10
, Article 158. 10.3389/fpsyt.2019.00158.
|
|
|
Stewart, W;
Allinson, K;
Al-Sarraj, S;
Bachmeier, C;
Barlow, K;
Belli, A;
Burns, MP;
... Smith, DH; + view all
(2019)
Primum non nocere: a call for balance when reporting on CTE.
Lancet Neurology
, 18
(3)
pp. 231-233.
10.1016/S1474-4422(19)30020-1.
|
|
|
Suarez-Gonzalez, A;
Ocal, D;
Pavisic, I;
Peacock, A;
Naessens, M;
Ahmed, S;
Butler, CR;
... Crutch, SJ; + view all
(2019)
ReadClear: An Assistive Reading Tool for People Living with Posterior Cortical Atrophy.
Journal of Alzheimer's Disease
10.3233/JAD-190335.
(In press).
|
|
|
Suárez-Pinilla, M;
Nikiforou, K;
Fountas, Z;
Seth, AK;
Roseboom, W;
(2019)
Perceptual Content, Not Physiological Signals, Determines Perceived Duration When Viewing Dynamic, Natural Scenes.
Collabra: Psychology
, 5
(1)
p. 55.
10.1525/collabra.234.
|
|
|
Sudre, CH;
Bocchetta, M;
Heller, C;
Convery, R;
Neason, M;
Moore, KM;
Cash, DM;
... Rohrer, JD; + view all
(2019)
White matter hyperintensities in progranulin-associated frontotemporal dementia – a longitudinal GENFI study.
NeuroImage: Clinical
, Article 102077. 10.1016/j.nicl.2019.102077.
(In press).
|
|
|
Sundal, C;
Carmona, S;
Yhr, M;
Almström, O;
Ljungberg, M;
Hardy, J;
Hedberg-Oldfors, C;
... Guerreiro, R; + view all
(2019)
An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids.
Acta Neuropathologica Communications
, 7
, Article 188. 10.1186/s40478-019-0843-y.
|
|
|
Swarup, V;
Hinz, FI;
Rexach, JE;
Noguchi, K-I;
Toyoshiba, H;
Oda, A;
Hirai, K;
... Geschwind, DH; + view all
(2019)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.
Nature Medicine
, 25
(1)
pp. 152-164.
10.1038/s41591-018-0223-3.
|
|
T
|
Tabrizi, SJ;
Ghosh, R;
Leavitt, BR;
(2019)
Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.
Neuron
, 101
(5)
pp. 801-819.
10.1016/j.neuron.2019.01.039.
|
|
Tabrizi, SJ;
Leavitt, BR;
Landwehrmeyer, GB;
Wild, EJ;
Saft, C;
Barker, RA;
Blair, NF;
... Lane, RM; + view all
(2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease.
The New England Journal of Medicine
, 380
pp. 2307-2316.
10.1056/NEJMoa1900907.
|
|
Tan, MMX;
Malek, N;
Lawton, MA;
Hubbard, L;
Pittman, AM;
Joseph, T;
Hehir, J;
... Morris, HR; + view all
(2019)
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Brain
10.1093/brain/awz191.
(In press).
|
|
|
Tavakol, S;
Royer, J;
Lowe, AJ;
Bonilha, L;
Tracy, JI;
Jackson, GD;
Duncan, JS;
... Bernhardt, BC; + view all
(2019)
Neuroimaging and connectomics of drug-resistant epilepsy at multiple scales: From focal lesions to macroscale networks.
Epilepsia
, 60
(4)
pp. 593-604.
10.1111/epi.14688.
|
|
Tavares, TP;
Mitchell, DGV;
Coleman, K;
Shoesmith, C;
Bartha, R;
Cash, DM;
Moore, KM;
... Genetic FTD Initiative, GENFI, .; + view all
(2019)
Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.
Neurology
10.1212/WNL.0000000000008386.
(In press).
|
|
|
Tektonidis, TG;
Coe, S;
Esser, P;
Maddock, J;
Buchanan, S;
Mavrommati, F;
Schott, JM;
... Dawes, H; + view all
(2019)
Diet quality in late midlife is associated with faster walking speed in later life in women, but not men: findings from a prospective British birth cohort.
British Journal of Nutrition
pp. 1-21.
10.1017/S0007114519003313.
(In press).
|
|
|
Thelin, EP;
Al Nimer, F;
Frostell, A;
Zetterberg, H;
Blennow, K;
Nyström, H;
Svensson, M;
... Nelson, DW; + view all
(2019)
A serum protein biomarker panel improves outcome prediction in human traumatic brain injury.
Journal of Neurotrauma
, 23
(20)
2850-2862..
10.1089/neu.2019.6375.
|
|
Timmers, M;
Tesseur, I;
Bogert, J;
Zetterberg, H;
Blennow, K;
Börjesson-Hanson, A;
Baquero, M;
... Streffer, JR; + view all
(2019)
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
Neurobiology of Aging
, 79
pp. 131-141.
10.1016/j.neurobiolaging.2019.03.016.
|
|
Toombs, Jamie;
(2019)
Amyloid beta: from pre-analytical factors to disease mechanisms.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Toomey, C;
Packham, G;
Foti, S;
Lashley, T;
(2019)
Investigating the role of astrocytes in TREM2 variant cases.
[Lecture].
Presented at: The 14th International conference on Alzheimer's and Parkinsons diseases, Lisbon, Portugal.
|
|
Toschi, N;
Lista, S;
Baldacci, F;
Cavedo, E;
Zetterberg, H;
Blennow, K;
Kilimann, I;
... Younsi, N; + view all
(2019)
Biomarker-guided clustering of Alzheimer's disease clinical syndromes.
Neurobiology of Aging
, 83
pp. 42-53.
10.1016/j.neurobiolaging.2019.08.032.
|
|
|
Trojsi, F;
Siciliano, M;
Femiano, C;
Santangelo, G;
Lunetta, C;
Calvo, A;
Moglia, C;
... Mondrioli, J; + view all
(2019)
Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients.
Frontiers in Neuroscience
, 13
, Article 485. 10.3389/fnins.2019.00485.
|
|
U
|
Underwood, J;
De Francesco, D;
Cole, JH;
Caan, MWA;
van Zoest, RA;
Schmand, BA;
Sharp, DJ;
... COmorBidity in Relation to AIDS (COBRA) Collaboration and the Ph, .; + view all
(2019)
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive Impairment.
Open Forum Infectious Diseases
, 6
(6)
10.1093/ofid/ofz198.
|
|
V
|
Vadgama, N;
Lamont, D;
Hardy, J;
Nasir, J;
Lovering, RC;
(2019)
Distinct proteomic profiles in monozygotic twins discordant for ischaemic stroke.
Molecular and Cellular Biochemistry
, 456
pp. 157-165.
10.1007/s11010-019-03501-2.
|
|
Vadgama, N;
Pittman, A;
Simpson, M;
Nirmalananthan, N;
Murray, R;
Yoshikawa, T;
De Rijk, P;
... Nasir, J; + view all
(2019)
De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes.
European Journal of Human Genetics
, 27
(7)
pp. 1121-1133.
10.1038/s41431-019-0376-7.
|
|
Vallabh, SM;
Nobuhara, CK;
Llorens, F;
Zerr, I;
Parchi, P;
Capellari, S;
Kuhn, E;
... Schreiber, SL; + view all
(2019)
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1901947116.
(In press).
|
|
|
van der Ende, EL;
Meeter, LH;
Poos, JM;
Panman, JL;
Jiskoot, LC;
Dopper, EGP;
Papma, JM;
... van Swieten, JC; + view all
(2019)
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.
The Lancet Neurology
, 18
(12)
pp. 1103-1111.
10.1016/S1474-4422(19)30354-0.
|
|
van der Lee, SJ;
Conway, OJ;
Jansen, I;
Carrasquillo, MM;
Kleineidam, L;
van den Akker, E;
Hernández, I;
... Holstege, H; + view all
(2019)
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Acta Neuropathologica
, 138
(2)
pp. 237-250.
10.1007/s00401-019-02026-8.
|
|
Varatharajah, Y;
Ramanan, VK;
Iyer, R;
Vemuri, P;
Alzheimer’s Disease Neuroimaging Initiative;
(2019)
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.
Scientific Reports
, 9
, Article 2235. 10.1038/s41598-019-38793-3.
|
|
|
Vergallo, A;
Megret, L;
Lista, S;
Cavedo, E;
Zetterberg, H;
Blennow, K;
Vanmechelen, E;
... Younesi, E; + view all
(2019)
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
Alzheimer's & Dementia
, 15
(6)
pp. 764-775.
10.1016/j.jalz.2019.03.009.
|
|
Vermunt, L;
Sikkes, SAM;
van den Hout, A;
Handels, R;
Bos, I;
van der Flier, WM;
Kern, S;
... ICTUS/DSA study groups, .; + view all
(2019)
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Alzheimer's and Dementia
, 15
(7)
pp. 888-898.
10.1016/j.jalz.2019.04.001.
|
|
Voevodskaya, O;
Poulakis, K;
Sundgren, P;
van Westen, D;
Palmqvist, S;
Wahlund, L-O;
Stomrud, E;
... Zetterberg, H; + view all
(2019)
Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
Neurology
, 92
(5)
E395-E405.
10.1212/WNL.0000000000006852.
|
|
|
Vogels, T;
Leuzy, A;
Cicognola, C;
Ashton, NJ;
Smolek, T;
Novak, M;
Blennow, K;
... Schöll, M; + view all
(2019)
Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Biological Psychiatry
10.1016/j.biopsych.2019.09.019.
(In press).
|
|
|
Vöglein, J;
Noachtar, S;
McDade, E;
Quaid, KA;
Salloway, S;
Ghetti, B;
Noble, J;
... Dominantly Inherited Alzheimer Network, .; + view all
(2019)
Seizures as an early symptom of autosomal dominant Alzheimer's disease.
Neurobiology of Aging
, 76
pp. 18-23.
10.1016/j.neurobiolaging.2018.11.022.
|
|
Vöglein, J;
Paumier, K;
Jucker, M;
Preische, O;
McDade, E;
Hassenstab, J;
Benzinger, TL;
... Dominantly Inherited Alzheimer Network, .; + view all
(2019)
Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
Brain
, 142
(5)
pp. 1429-1440.
10.1093/brain/awz050.
|
|
Volkmer, A;
Rogalski, E;
Henry, M;
Taylor-Rubin, C;
Ruggero, L;
Khayum, R;
Kindell, J;
... Rohrer, JD; + view all
(2019)
Speech and language therapy approaches to managing primary progressive aphasia.
Practical Neurology
10.1136/practneurol-2018-001921.
(In press).
|
|
|
Volkmer, A;
Spector, A;
Meitanis, V;
Warren, JD;
Beeke, S;
(2019)
Effects of functional communication interventions for people with primary progressive aphasia and their caregivers: a systematic review.
Aging & Mental Health
10.1080/13607863.2019.1617246.
(In press).
|
|
Volkmer, A;
Spector, A;
Warren, JD;
Beeke, S;
(2019)
Speech and language therapy for primary progressive aphasia across the UK: A survey of current practice.
International Journal of Language & Communication Disorders
, 54
(6)
pp. 914-926.
10.1111/1460-6984.12495.
|
|
Vollstedt, E-J;
Kasten, M;
Klein, C;
MJFF Global Genetic Parkinson's Disease Study Group;
(2019)
Using global team science to identify genetic parkinson's disease worldwide.
Annals of Neurology
, 86
(2)
pp. 153-157.
10.1002/ana.25514.
|
W
|
Walton, E;
Hibar, D;
Yilmaz, Z;
Jahanshad, N;
Cheung, J;
Batury, V-L;
Seitz, J;
... Bulik, CM; + view all
(2019)
Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia Nervosa.
Molecular Neurobiology
, 56
(7)
pp. 5146-5156.
10.1007/s12035-018-1439-4.
|
|
|
Warren-Gash, C;
Forbes, HJ;
Williamson, E;
Breuer, J;
Hayward, AC;
Mavrodaris, A;
Ridha, BH;
... Smeeth, L; + view all
(2019)
Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis.
Scientific Reports
, 9
(1)
, Article 4743. 10.1038/s41598-019-41218-w.
|
|
|
Weaver, NA;
Zhao, L;
Biesbroek, JM;
Kuijf, HJ;
Aben, HP;
Bae, H-J;
Caballero, MÁA;
... Biessels, GJ; + view all
(2019)
The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 310-326.
10.1016/j.dadm.2019.02.007.
|
|
|
Wehrli, PM;
Michno, W;
Blennow, K;
Zetterberg, H;
Hanrieder, J;
(2019)
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data.
Journal of The American Society for Mass Spectrometry
, 30
pp. 2278-2288.
10.1007/s13361-019-02327-y.
|
|
|
Weiffert, T;
Meisl, G;
Flagmeier, P;
De, S;
Dunning, CJR;
Frohm, B;
Zetterberg, H;
... Linse, S; + view all
(2019)
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
ACS Chemical Neuroscience
, 10
(5)
pp. 2374-2384.
10.1021/acschemneuro.8b00676.
|
|
Weil, R;
Fox, M;
Hsu, J;
Darby, R;
Soussan, L;
(2019)
Neuroimaging in Parkinson's disease dementia: Connecting the dots.
Brain Communications
, 1
(1)
, Article fcz006. 10.1093/braincomms/fcz006.
(In press).
|
|
|
Weil, R;
Winston, J;
Leyland, L;
Pappa, K;
Mahmood, R;
Morris, H;
Rees, G;
(2019)
Neural correlates of early cognitive dysfunction in Parkinson’s disease.
Annals of Clinical and Translational Neurology
, 6
(5)
pp. 902-912.
10.1002/acn3.767.
|
|
|
Weil, R;
Zarkali, A;
Lees, A;
(2019)
Flickering stimuli do not reliably induce visual hallucinations in Parkinson's disease.
Journal of Parkinson's Disease
, 9
(3)
pp. 631-635.
10.3233/JPD-191635.
|
|
|
Weil, RS;
Morris, HR;
(2019)
REM sleep behaviour disorder: an early window for prevention in neurodegeneration?
Brain
, 142
(3)
pp. 498-501.
10.1093/brain/awz014.
|
|
Weston, PSJ;
Poole, T;
O'Connor, A;
Heslegrave, A;
Ryan, NS;
Liang, Y;
Druyeh, R;
... Fox, NC; + view all
(2019)
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.
Alzheimer's Research & Therapy
, 11
, Article 19. 10.1186/s13195-019-0472-5.
|
|
|
Wharton, W;
Kollhoff, AL;
Gangishetti, U;
Verble, DD;
Upadhya, S;
Zetterberg, H;
Kumar, V;
... Hu, WT; + view all
(2019)
Interleukin 9 alterations linked to alzheimer disease in african americans.
Annals of Neurology
, 86
(3)
pp. 407-418.
10.1002/ana.25543.
|
|
Wild, EJ;
Tabrizi, SJ;
(2019)
One decade ago, one decade ahead in huntington's disease.
Movement Disorders
, 34
(10)
pp. 1434-1439.
10.1002/mds.27849.
|
|
Wilke, C;
Pujol-Calderón, F;
Barro, C;
Stransky, E;
Blennow, K;
Michalak, Z;
Deuschle, C;
... Synofzik, M; + view all
(2019)
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
Clinical Chemistry and Laboratory Medicine
, 57
(10)
pp. 1556-1564.
10.1515/cclm-2019-0015.
|
|
Williams, G;
Gatt, A;
Clarke, E;
Corcoran, J;
Doherty, P;
Chambers, D;
Ballard, C;
(2019)
Drug repurposing for Alzheimer’s disease based on transcriptional profiling of human iPSC-derived cortical neurons.
Translational Psychiatry
, 9
, Article 220. 10.1038/s41398-019-0555-x.
|
|
|
Wilson, KM;
Muralidharan, B;
Isaacs, AM;
(2019)
Relax, Don't RAN Translate It.
Neuron
, 104
(5)
pp. 827-829.
10.1016/j.neuron.2019.11.014.
|
|
Winblad, B;
Ankarcrona, M;
Johansson, G;
Novak, P;
Peter Thelin, E;
Zetterberg, H;
Blennow, K;
(2019)
Head trauma in sports and risk for dementia.
Journal of Internal Medicine
, 285
(6)
pp. 591-593.
10.1111/joim.12918.
|
|
Wittenberg, R;
Knapp, M;
Karagiannidou, M;
Dickson, J;
Schott, J;
(2019)
Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 5
pp. 382-387.
10.1016/j.trci.2019.06.001.
|
|
|
Wu, J;
Hasselgren, C;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
Halleröd, B;
(2019)
The impact of social networks and APOE ε4 on dementia among older adults: tests of possible interactions.
Aging and Mental Health
10.1080/13607863.2018.1531368.
|
X
|
Xie, S;
Li, X;
McColgan, P;
Scahill, RI;
Zeng, D;
Wang, Y;
(2019)
Identifying disease-associated biomarker network features through conditional graphical model.
Biometrics
10.1111/biom.13201.
(In press).
|
Y
|
Yilmaz, A;
Fuchs, D;
Price, RW;
Spudich, S;
Blennow, K;
Zetterberg, H;
Gisslén, M;
(2019)
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
Current HIV/AIDS Reports
10.1007/s11904-019-00420-1.
(In press).
|
|
|
Yilmaz, A;
Mellgren, Å;
Fuchs, D;
Nilsson, S;
Blennow, K;
Zetterberg, H;
Gisslén, M;
(2019)
Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection.
Infectious Diseases
, 51
(11-12)
pp. 838-846.
10.1080/23744235.2019.1670352.
|
Z
|
Zarkali, A;
Adams, R;
Psarras, S;
Leyland, L;
Rees, G;
Weil, R;
(2019)
Increased weighting on prior knowledge in Lewy Body-associated visual hallucinations.
Brain Communications
, 1
(1)
10.1093/braincomms/fcz007.
|
|
|
Zetterberg, H;
(2019)
Blood-based biomarkers for Alzheimer's disease—An update.
Journal of Neuroscience Methods
, 319
pp. 2-6.
10.1016/j.jneumeth.2018.10.025.
|
|
Zetterberg, H;
Apostolova, LG;
Snyder, PJ;
(2019)
Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 784-786.
10.1016/j.dadm.2019.10.001.
(In press).
|
|
|
Zetterberg, H;
Bähr, M;
(2019)
Disease signatures: Biomarkers/indicators of neurodegeneration.
Molecular and Cellular Neuroscience
, 97
pp. 1-2.
10.1016/j.mcn.2019.05.004.
|
|
Zetterberg, H;
Bozzetta, E;
Favole, A;
Corona, C;
Cavarretta, MC;
Ingravalle, F;
Blennow, K;
... Meloni, D; + view all
(2019)
Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep.
PLOS ONE
, 14
(12)
, Article e0226697. 10.1371/journal.pone.0226697.
|
|
|
Zetterberg, H;
Burnham, SC;
(2019)
Blood-based molecular biomarkers for Alzheimer's disease.
Molecular Brain
, 12
, Article 26. 10.1186/s13041-019-0448-1.
|
|
|
Zetterberg, H;
Compta, Y;
(2019)
A tear fluid proteome of Parkinson's disease.
Parkinsonism & Related Disorders
, 63
pp. 1-2.
10.1016/j.parkreldis.2019.07.028.
|
|
Zetterberg, H;
Schott, JM;
(2019)
Biomarkers for Alzheimer's disease beyond amyloid and tau.
Nature Medicine
, 25
(2)
pp. 201-203.
10.1038/s41591-019-0348-z.
|
|
Zetterberg, H;
Svenningsson, A;
(2019)
Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.
Neurology
, 92
(7)
pp. 313-314.
10.1212/WNL.0000000000006906.
|
|
Zetterberg, H;
Van Swieten, JC;
Boxer, AL;
Rohrer, JD;
(2019)
Fluid biomarkers for frontotemporal dementias.
Neuropathology and Applied Neurobiology
, 45
(1)
pp. 81-87.
10.1111/nan.12530.
|
|
Zetterberg, H;
Winblad, B;
Bernick, C;
Yaffe, K;
Majdan, M;
Johansson, G;
Newcombe, V;
... Blennow, K; + view all
(2019)
Head trauma in sports – clinical characteristics, epidemiology and biomarkers.
Journal of Internal Medicine
, 285
(6)
pp. 624-634.
10.1111/joim.12863.
|
|
Zettergren, A;
Hoglund, K;
Kern, S;
Thorvaldsson, V;
Skoog, J;
Hansson, O;
Andreasen, N;
... Zetterberg, H; + view all
(2019)
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.
Scientific Reports
, 9
(2460)
10.1038/s41598-018-36650-3.
|
|
|
Zeun, P;
Scahill, R;
Tabrizi, S;
Wild, E;
(2019)
Fluid and Imaging Biomarkers for Huntington's Disease.
Molecular and Cellular Neuroscience
, 97
pp. 67-80.
10.1016/j.mcn.2019.02.004.
|
|
Zhang, H;
Huntley, J;
Bhome, R;
Holmes, B;
Cahill, J;
Gould, R;
Wang, H;
... Howard, R; + view all
(2019)
The effect of Computerized Cognitive Training on cognitive outcomes in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
BMJ Open
10.1136/bmjopen-2018-027062.
|
|
|
Zhang, Y;
Pusch, S;
Innes, J;
Sidlauskas, K;
Ellis, M;
Lau, J;
El-Hassan, T;
... Brandner, S; + view all
(2019)
Mutant IDH Sensitizes Gliomas to Endoplasmic Reticulum Stress and Triggers Apoptosis via miR-183-Mediated Inhibition of Semaphorin 3E.
Cancer Research
, 79
(19)
pp. 4994-5007.
10.1158/0008-5472.CAN-19-0054.
|
|
Zhong, X;
Wang, J;
Carlsson, C;
Okonkwo, O;
Zetterberg, H;
Li, L;
(2019)
A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer's Disease.
Frontiers in Molecular Neuroscience
, 11
, Article 483. 10.3389/fnmol.2018.00483.
|
|
|
Zhong, X;
Yu, Q;
Ma, F;
Frost, DC;
Lu, L;
Chen, Z;
Zetterberg, H;
... Li, L; + view all
(2019)
HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics.
Analytical Chemistry
, 91
(3)
pp. 2112-2119.
10.1021/acs.analchem.8b04580.
|
|
Zhou, X;
Chen, Y;
Mok, KY;
Kwok, TCY;
Mok, VCT;
Guo, Q;
Ip, FC;
... Furst, AJ; + view all
(2019)
Non-coding variability at the APOE locus contributes to the Alzheimer's risk.
Nature Communications
, 10
, Article 3310. 10.1038/s41467-019-10945-z.
|
|
